CD45	B-protein
tyrosine	I-protein
phosphatase	I-protein
controls	O
common	O
gamma-chain	B-protein
cytokine	I-protein
-mediated	O
STAT	B-protein
and	O
extracellular	O
signal-related	O
kinase	O
phosphorylation	O
in	O
activated	B-cell_type
human	I-cell_type
lymphoblasts	I-cell_type
:	O
inhibition	O
of	O
proliferation	O
without	O
induction	O
of	O
apoptosis	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
test	O
whether	O
CD45	O
signals	O
can	O
influence	O
signaling	O
processes	O
in	O
activated	B-cell_type
human	I-cell_type
lymphoblasts	I-cell_type
.	O

To	O
this	O
end	O
,	O
we	O
generated	O
lymphoblasts	B-cell_type
which	O
proliferate	O
in	O
response	O
to	O
common	O
gamma-chain	B-protein
cytokines	I-protein
,	O
but	O
readily	O
undergo	O
apoptosis	O
after	O
cytokine	O
withdrawal	O
.	O

In	O
experiments	O
with	O
the	O
CD45R0	B-protein
mAb	I-protein
UCHL-1	I-protein
,	O
but	O
not	O
control	B-protein
CD45	I-protein
mAbs	I-protein
,	O
we	O
found	O
significant	O
inhibition	O
of	O
proliferation	O
.	O

Interestingly	O
,	O
the	O
pan-CD45	B-protein
mAb	I-protein
GAP8.3	I-protein
,	O
which	O
is	O
most	O
effective	O
in	O
inhibition	O
of	O
OKT-3-mediated	O
proliferation	O
in	O
quiescent	B-cell_type
lymphocytes	I-cell_type
,	O
was	O
ineffective	O
in	O
lymphoblasts	B-cell_type
.	O

Addition	O
of	O
CD3	B-protein
mAb	I-protein
OKT-3	I-protein
had	O
no	O
influence	O
on	O
IL-2-mediated	O
proliferation	O
(	O
with	O
or	O
without	O
UCHL-1	B-protein
)	O
.	O

In	O
contrast	O
,	O
after	O
addition	O
of	O
OKT-3	B-protein
to	O
IL-4	B-protein
-	O
and	O
IL-7	B-protein
-stimulated	O
proliferation	O
assays	O
,	O
UCHL-1	B-protein
signals	O
could	O
not	O
significantly	O
alter	O
cellular	O
proliferation	O
.	O

We	O
did	O
not	O
find	O
induction	O
of	O
apoptosis	O
following	O
CD45R0	O
signaling	O
.	O

In	O
Western	O
blots	O
using	O
mAbs	B-protein
detecting	O
phosphorylated	B-protein
STAT-3	I-protein
,	I-protein
STAT-5	I-protein
,	I-protein
STAT-6	I-protein
,	O
or	O
extracellular	B-protein
signal-related	I-protein
kinase	I-protein
1/2	I-protein
,	O
we	O
found	O
that	O
CD45R0	O
signaling	O
could	O
effectively	O
diminish	O
phosphorylation	O
of	O
these	O
intracellular	O
signaling	O
components	O
.	O

Using	O
RT-PCR	O
,	O
we	O
found	O
that	O
CD45R0	O
signaling	O
inhibited	O
IL-2	O
mRNA	O
production	O
without	O
major	O
influence	O
on	O
IL-13	B-protein
,	O
IL-5	B-protein
,	O
or	O
IFN-gamma	B-RNA
mRNA	I-RNA
levels	O
.	O

Costimulation	O
with	O
OKT-3	B-protein
and	O
IL-2	B-protein
optimally	O
induced	O
secretion	O
of	O
IFN-gamma	B-protein
,	O
TNF-alpha	B-protein
,	O
and	O
IL-5	B-protein
,	O
which	O
was	O
not	O
decreased	O
by	O
CD45	O
signals	O
.	O

In	O
conclusion	O
,	O
we	O
illustrate	O
that	O
CD45R0	O
signals	O
control	O
early	O
cytokine	O
receptor-associated	O
signaling	O
processes	O
and	O
mRNA	O
and	O
DNA	O
synthesis	O
in	O
activated	B-cell_type
human	I-cell_type
lymphoblasts	I-cell_type
.	O

Furthermore	O
,	O
we	O
show	O
the	O
existence	O
of	O
CD45	B-protein
epitopes	I-protein
(	O
GAP8.3	B-protein
)	O
,	O
which	O
are	O
active	O
and	O
critical	O
for	O
signaling	O
in	O
quiescent	B-cell_type
lymphocytes	I-cell_type
,	O
but	O
are	O
nonfunctional	O
in	O
activated	B-cell_type
human	I-cell_type
lymphoblasts	I-cell_type
.	O

.	NULL

2	NULL
nozzles	NULL
per	NULL
well	NULL
enable	NULL
cell	NULL
A	NULL
Check	NULL
out	NULL
how	NULL
Laminar	NULL
Wash	NULL
l	NULL
washing	NULL
by	NULL
creating	NULL
a	NULL
laminar	NULL
I	NULL
“	NULL
CU	NULL
RIOX	NULL
systems	NULL
replace	NULL
centrifugation	NULL
completely	NULL
in	NULL
handling	NULL
cells	NULL
See	NULL
How	NULL
It	NULL
Works	NULL
Accelerating	NULL
Life	NULL
Sciences	NULL
Kp	NULL
mJournal	NULL
f	NULL
CD45	NULL
Tyrosine	NULL
lfhosphatjclse	NULL
Controls	NULL
U*	NULL
Immunolo	NULL
gy	NULL
Common	NULL
y-Chain	NULL
Cytokine-Mediated	NULL
STAT	NULL
and	NULL
Extracellular	NULL
Signal-Related	NULL
Kinase	NULL
10	NULL
,	NULL
2	NULL
,	NULL
Phosphorylation	NULL
in	NULL
Activated	NULL
Human	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
_	NULL
Lymphoblasts	NULL
:	NULL
Inhibition	NULL
of	NULL
Proliferation	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Without	NULL
Induction	NULL
of	NULL
Apoptosis	NULL
Norbert	NULL
Blank	NULL
,	NULL
Martin	NULL
Kriegel	NULL
,	NULL
Thomas	NULL
Hieronymus	NULL
,	NULL
Thomas	NULL
Geiler	NULL
,	NULL
Silke	NULL
Winkler	NULL
,	NULL
Joachim	NULL
R.	NULL
Kalden	NULL
and	NULL
Hanns-Martin	NULL
Lorenz	NULL
J	NULL
Immunol	NULL
2001	NULL
;	NULL
166:6034-6040	NULL
;	NULL
;	NULL
doi	NULL
:	NULL
10.4049/jimmunol.166.10.6034	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/10/6034	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
55	NULL
articles	NULL
,	NULL
24	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/10/6034	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
CD45	NULL
Tyrosine	NULL
Phosphatase	NULL
Controls	NULL
Common	NULL
y-Chain	NULL
Cytokine-Mediated	NULL
STAT	NULL
and	NULL
Extracellular	NULL
Signal-Related	NULL
Kinase	NULL
Phosphorylation	NULL
in	NULL
Activated	NULL
Human	NULL
Lymphoblasts	NULL
:	NULL
Inhibition	NULL
of	NULL
Proliferation	NULL
Without	NULL
Induction	NULL
of	NULL
Apoptosis	NULL
'	NULL
Norbert	NULL
Blank	NULL
,	NULL
``	NULL
Martin	NULL
Kriegel	NULL
,	NULL
``	NULL
Thomas	NULL
Hieronymus	NULL
,	NULL
Thomas	NULL
Geiler	NULL
,	NULL
Silke	NULL
Winkler	NULL
,	NULL
Joachim	NULL
R.	NULL
Kalden	NULL
,	NULL
and	NULL
Hanns-Martin	NULL
Lorenz	NULL
The	NULL
objective	NULL
of	NULL
this	NULL
study	NULL
was	NULL
to	NULL
test	NULL
whether	NULL
CD45	NULL
signals	NULL
can	NULL
influence	NULL
signaling	NULL
processes	NULL
in	NULL
activated	NULL
human	NULL
lymphoblasts	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
we	NULL
generated	NULL
lymphoblasts	NULL
which	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
common	NULL
y-chain	NULL
cytokines	NULL
,	NULL
but	NULL
readily	NULL
undergo	NULL
apoptosis	NULL
after	NULL
cytokine	NULL
withdrawal	NULL
.	NULL

In	NULL
experiments	NULL
with	NULL
the	NULL
CD4SRO	NULL
mAb	NULL
UCHL-1	NULL
,	NULL
but	NULL
not	NULL
control	NULL
CD45	NULL
mAbs	NULL
,	NULL
we	NULL
found	NULL
significant	NULL
inhibition	NULL
of	NULL
proliferation	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
pan-CD45	NULL
mAb	NULL
GAP8.3	NULL
,	NULL
which	NULL
is	NULL
most	NULL
effective	NULL
in	NULL
inhibition	NULL
of	NULL
OKT-3-mediated	NULL
proliferation	NULL
in	NULL
quiescent	NULL
lymphocytes	NULL
,	NULL
was	NULL
ineffective	NULL
in	NULL
lymphoblasts	NULL
.	NULL

Addition	NULL
of	NULL
CD3	NULL
mAb	NULL
OKT-3	NULL
had	NULL
no	NULL
influence	NULL
on	NULL
IL-2-mediated	NULL
proliferation	NULL
(	NULL
with	NULL
or	NULL
without	NULL
UCHL-1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
after	NULL
addition	NULL
of	NULL
OKT-3	NULL
to	NULL
IL-4-	NULL
and	NULL
IL-7-stimulated	NULL
proliferation	NULL
assays	NULL
,	NULL
UCHL-1	NULL
signals	NULL
could	NULL
not	NULL
significantly	NULL
alter	NULL
cellular	NULL
proliferation	NULL
.	NULL

We	NULL
did	NULL
not	NULL
find	NULL
induction	NULL
of	NULL
apoptosis	NULL
following	NULL
CD45R0	NULL
signaling	NULL
.	NULL

In	NULL
Western	NULL
blots	NULL
using	NULL
mAbs	NULL
detecting	NULL
phosphorylated	NULL
STAT-3	NULL
,	NULL
STAT-5	NULL
,	NULL
STAT-6	NULL
,	NULL
or	NULL
extracellular	NULL
signal-related	NULL
kinase	NULL
1/2	NULL
,	NULL
we	NULL
found	NULL
that	NULL
CD4SRO	NULL
signaling	NULL
could	NULL
effectively	NULL
diminish	NULL
phosphorylation	NULL
of	NULL
these	NULL
intracellular	NULL
signaling	NULL
components	NULL
.	NULL

Using	NULL
RT-PCR	NULL
,	NULL
we	NULL
found	NULL
that	NULL
CD4S5RO	NULL
signaling	NULL
inhibited	NULL
IL-2	NULL
mRNA	NULL
production	NULL
without	NULL
major	NULL
influence	NULL
on	NULL
IL-13	NULL
,	NULL
IL-5	NULL
,	NULL
or	NULL
IFN-y	NULL
mRNA	NULL
levels	NULL
.	NULL

Costimulation	NULL
with	NULL
OKT-3	NULL
and	NULL
IL-2	NULL
optimally	NULL
induced	NULL
secretion	NULL
of	NULL
IFN-y	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
IL-5	NULL
,	NULL
which	NULL
was	NULL
not	NULL
decreased	NULL
by	NULL
CD45	NULL
signals	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
illustrate	NULL
that	NULL
CD4SRO	NULL
signals	NULL
control	NULL
early	NULL
cytokine	NULL
receptor-associated	NULL
signaling	NULL
processes	NULL
and	NULL
mRNA	NULL
and	NULL
DNA	NULL
synthesis	NULL
in	NULL
activated	NULL
human	NULL
lymphoblasts	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
show	NULL
the	NULL
existence	NULL
of	NULL
CD45	NULL
epitopes	NULL
(	NULL
GAP38.3	NULL
)	NULL
,	NULL
which	NULL
are	NULL
active	NULL
and	NULL
critical	NULL
for	NULL
signaling	NULL
in	NULL
quiescent	NULL
lymphocytes	NULL
,	NULL
but	NULL
are	NULL
nonfunctional	NULL
in	NULL
activated	NULL
human	NULL
lymphoblasts	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
2001	NULL
,	NULL
166	NULL
:	NULL
6034-6040.	NULL
dant	NULL
surface	NULL
protein	NULL
on	NULL
leukocytes	NULL
,	NULL
CD45	NULL
(	NULL
leukocyte	NULL
common	NULL
Ag	NULL
)	NULL
still	NULL
eludes	NULL
definition	NULL
.	NULL

We	NULL
and	NULL
other	NULL
investigators	NULL
reported	NULL
CD45	NULL
mAbs	NULL
to	NULL
be	NULL
inhibitory	NULL
to	NULL
T	NULL
and	NULL
B	NULL
lymphocyte	NULL
proliferation	NULL
(	NULL
1-6	NULL
)	NULL
as	NULL
well	NULL
as	NULL
basophil	NULL
degranulation	NULL
(	NULL
7	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
CD45	NULL
expression	NULL
also	NULL
seems	NULL
to	NULL
be	NULL
an	NULL
absolute	NULL
prerequisite	NULL
for	NULL
T	NULL
and	NULL
B	NULL
lymphocyte	NULL
activation	NULL
(	NULL
8-14	NULL
)	NULL
.	NULL

Perhaps	NULL
the	NULL
major	NULL
contender	NULL
for	NULL
transduction	NULL
of	NULL
intracellular	NULL
signals	NULL
following	NULL
CD45	NULL
cross-linking	NULL
is	NULL
the	NULL
phosphotyrosine	NULL
phosphatase	NULL
enzyme	NULL
activity	NULL
located	NULL
in	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
€D45	NULL
(	NULL
15-18	NULL
)	NULL
.	NULL

This	NULL
705	NULL
aa	NULL
domain	NULL
apparently	NULL
causes	NULL
constitutive	NULL
dephosphorylation	NULL
of	NULL
its	NULL
substrate	NULL
p56	NULL
``	NULL
at	NULL
Tyr	NULL
``	NULL
,	NULL
leading	NULL
to	NULL
its	NULL
subsequent	NULL
activation	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
in	NULL
CD4S5-negative	NULL
cell	NULL
lines	NULL
decreased	NULL
p59	NULL
``	NULL
activity	NULL
was	NULL
described	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Retransfection	NULL
of	NULL
CD45	NULL
into	NULL
these	NULL
cells	NULL
leads	NULL
to	NULL
p56	NULL
``	NULL
activation	NULL
.	NULL

This	NULL
was	NULL
coupled	NULL
to	NULL
increased	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
augmentation	NULL
of	NULL
phospholipase	NULL
Cy1	NULL
T	NULL
he	NULL
precise	NULL
physiological	NULL
significance	NULL
of	NULL
the	NULL
most	NULL
abun-	NULL
Department	NULL
of	NULL
Medicine	NULL
III	NULL
,	NULL
Institute	NULL
for	NULL
Clinical	NULL
Immunology	NULL
and	NULL
Rheumatology	NULL
,	NULL
University	NULL
of	NULL
Erlangen-Nuremberg	NULL
,	NULL
Erlangen	NULL
,	NULL
Germany	NULL
Received	NULL
for	NULL
publication	NULL
February	NULL
22	NULL
,	NULL
2000	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
March	NULL
9	NULL
,	NULL
2001	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
German	NULL
Research	NULL
Association	NULL
(	NULL
Deut-sche	NULL
Forschungsgemeinschaft	NULL
,	NULL
Sonderforschungsbereich	NULL
263	NULL
)	NULL
and	NULL
the	NULL
Bundesminis-terium	NULL
fur	NULL
Bildung	NULL
,	NULL
Wissenschaft	NULL
,	NULL
Forschung	NULL
und	NULL
Technologie	NULL
(	NULL
to	NULL
H.-M.L	NULL
.	NULL
)	NULL

.	NULL

2	NULL
N.B	NULL
.	NULL

and	NULL
MK	NULL
.	NULL

equally	NULL
contributed	NULL
to	NULL
this	NULL
work	NULL
.	NULL

°	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Hanns-Martin	NULL
Lorenz	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
IIL	NULL
,	NULL
Institute	NULL
for	NULL
Rheumatology	NULL
and	NULL
Clinical	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Erlangen-Nuremberg	NULL
,	NULL
Krankenhausstrasse	NULL
12	NULL
,	NULL
91054	NULL
Erlangen	NULL
,	NULL
Germany	NULL
.	NULL

Email	NULL
address	NULL
:	NULL
Hannes.Lorenz	NULL
@	NULL
med3.imed.uni-erlangen.de	NULL
Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
activity	NULL
,	NULL
resulting	NULL
in	NULL
Ca**	NULL
flux	NULL
(	NULL
21-24	NULL
)	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
.	NULL
``	NULL

Desai	NULL
et	NULL
al	NULL
.	NULL

and	NULL
Majeti	NULL
et	NULL
al	NULL
.	NULL

(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
dimerization	NULL
of	NULL
CD45	NULL
(	NULL
after	NULL
binding	NULL
of	NULL
epidermal	NULL
growth	NULL
factor	NULL
in	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor-CD45	NULL
chimera	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
,	NULL
binding	NULL
of	NULL
mAb	NULL
)	NULL
switches	NULL
phosphatase	NULL
activity	NULL
off	NULL
,	NULL
leading	NULL
to	NULL
autophosphorylation	NULL
of	NULL
the	NULL
negative	NULL
regulatory	NULL
Tyr®	NULL
``	NULL
and	NULL
subsequent	NULL
deactivation	NULL
of	NULL
p56	NULL
``	NULL
.	NULL

However	NULL
,	NULL
this	NULL
notion	NULL
has	NULL
recently	NULL
been	NULL
challenged	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
in	NULL
thymocytes	NULL
of	NULL
CD45	NULL
knockout	NULL
mice	NULL
p56	NULL
``	NULL
*	NULL
is	NULL
hyperphosphorylated	NULL
at	NULL
its	NULL
positive	NULL
regulatory	NULL
Tyr®	NULL
``	NULL
*	NULL
,	NULL
with	NULL
its	NULL
activity	NULL
being	NULL
elevated	NULL
2-	NULL
to	NULL
4-fold	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Some	NULL
investigators	NULL
have	NULL
also	NULL
reported	NULL
costimulatory	NULL
rather	NULL
than	NULL
inhibitory	NULL
properties	NULL
of	NULL
different	NULL
€D45	NULL
mAbs	NULL
upon	NULL
T	NULL
cell	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
and	NULL
B	NULL
cell	NULL
activation	NULL
(	NULL
31	NULL
)	NULL
,	NULL
again	NULL
highlighting	NULL
epitope	NULL
specificity	NULL
of	NULL
CD45	NULL
signaling	NULL
processes	NULL
.	NULL

CD45	NULL
seems	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
coupling	NULL
the	NULL
TCR	NULL
to	NULL
the	NULL
phosphatidyl	NULL
inositol	NULL
pathway	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Cross-linking	NULL
of	NULL
CD45	NULL
with	NULL
certain	NULL
mAbs	NULL
diminishes	NULL
both	NULL
inositol	NULL
phosphate	NULL
formation	NULL
and	NULL
Ca	NULL
``	NULL
*	NULL
flux	NULL
upon	NULL
stimulation	NULL
with	NULL
CD3/TCR	NULL
or	NULL
CD2	NULL
(	NULL
8	NULL
,	NULL
22	NULL
,	NULL
23	NULL
,	NULL
32-34	NULL
)	NULL
,	NULL
again	NULL
suggesting	NULL
a	NULL
major	NULL
role	NULL
for	NULL
CD45	NULL
in	NULL
regulating	NULL
early	NULL
intracellular	NULL
signaling	NULL
processes	NULL
in	NULL
lymphocytes	NULL
.	NULL

Recently	NULL
,	NULL
an	NULL
association	NULL
of	NULL
€D45	NULL
to	NULL
lipid	NULL
microdomains	NULL
as	NULL
major	NULL
platforms	NULL
regulating	NULL
signal	NULL
transduction	NULL
has	NULL
been	NULL
discussed	NULL
(	NULL
35	NULL
)	NULL
.	NULL

In	NULL
this	NULL
model	NULL
,	NULL
CD45	NULL
cells	NULL
release	NULL
activated	NULL
p56	NULL
``	NULL
into	NULL
the	NULL
microdomain	NULL
(	NULL
dephosphorylated	NULL
on	NULL
Tyr®~	NULL
``	NULL
)	NULL
,	NULL
enabling	NULL
signal	NULL
transduction	NULL
through	NULL
the	NULL
TCR-CD3-CD4	NULL
complex	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

A	NULL
prerequisite	NULL
for	NULL
this	NULL
model	NULL
is	NULL
that	NULL
CD45	NULL
is	NULL
excluded	NULL
from	NULL
,	NULL
but	NULL
still	NULL
is	NULL
very	NULL
close	NULL
to	NULL
,	NULL
*	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
y..	NULL
,	NULL
common	NULL
y-chain	NULL
;	NULL
ERK	NULL
,	NULL
extracellular	NULL
signal-related	NULL
kinase	NULL
;	NULL
PI	NULL
,	NULL
propidium	NULL
iodide	NULL
;	NULL
Jak	NULL
,	NULL
Janus	NULL
kinase	NULL
.	NULL

0022-1767/01/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
the	NULL
lipid	NULL
microdomain	NULL
.	NULL

This	NULL
represents	NULL
a	NULL
new	NULL
mechanistic	NULL
model	NULL
which	NULL
might	NULL
help	NULL
explaining	NULL
the	NULL
partially	NULL
contradictory	NULL
findings	NULL
in	NULL
CD45	NULL
signaling	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
results	NULL
associating	NULL
decreased	NULL
PKC	NULL
activity	NULL
and	NULL
T	NULL
cell	NULL
inactivation	NULL
with	NULL
CD45-transduced	NULL
signaling	NULL
,	NULL
our	NULL
previous	NULL
findings	NULL
suggest	NULL
an	NULL
additional	NULL
role	NULL
for	NULL
CD4S5-triggered	NULL
signaling	NULL
,	NULL
namely	NULL
,	NULL
cellular	NULL
adhesion	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
triggering	NULL
of	NULL
PBMCs	NULL
with	NULL
certain	NULL
mAbs	NULL
to	NULL
CD45	NULL
,	NULL
CD45RA	NULL
,	NULL
or	NULL
CD45RO	NULL
leads	NULL
to	NULL
LFA-1/ICAM-1-dependent	NULL
,	NULL
heterotypic	NULL
cellular	NULL
aggregation	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
CD45	NULL
-associated	NULL
phenomena	NULL
occur	NULL
independent	NULL
of	NULL
PKC	NULL
activation	NULL
and	NULL
appear	NULL
to	NULL
be	NULL
linked	NULL
to	NULL
subsequent	NULL
activation	NULL
of	NULL
cAMP/cGMP-dependent	NULL
kinases	NULL
(	NULL
3	NULL
,	NULL
37	NULL
)	NULL
.	NULL

We	NULL
could	NULL
demonstrate	NULL
(	NULL
38	NULL
)	NULL
that	NULL
triggering	NULL
CD45	NULL
through	NULL
certain	NULL
epitopes	NULL
induces	NULL
intracellular	NULL
cAMP	NULL
accumulation	NULL
and	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
A	NULL
in	NULL
a	NULL
dose-	NULL
and	NULL
time-dependent	NULL
fashion	NULL
.	NULL

This	NULL
cAMP	NULL
synthesis	NULL
did	NULL
not	NULL
occur	NULL
in	NULL
purified	NULL
resting	NULL
T	NULL
cells	NULL
and	NULL
required	NULL
presence	NULL
of	NULL
viable	NULL
monocytes	NULL
.	NULL

Blockade	NULL
of	NULL
T	NULL
cell-monocyte	NULL
interactions	NULL
with	NULL
ICAM-1	NULL
mAb	NULL
could	NULL
prevent	NULL
cAMP	NULL
synthesis	NULL
(	NULL
38	NULL
)	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
role	NULL
of	NULL
CD45	NULL
signaling	NULL
in	NULL
activated	NULL
human	NULL
lymphoblasts	NULL
.	NULL

We	NULL
herein	NULL
describe	NULL
that	NULL
signals	NULL
through	NULL
CD45RO	NULL
can	NULL
inhibit	NULL
proliferation	NULL
and	NULL
mRNA	NULL
synthesis	NULL
after	NULL
stimulation	NULL
with	NULL
common	NULL
y-chain	NULL
(	NULL
7	NULL
,	NULL
)	NULL
cytokines	NULL
.	NULL

Studying	NULL
intracellular	NULL
signaling	NULL
events	NULL
we	NULL
found	NULL
that	NULL
cosignaling	NULL
through	NULL
CD45RO	NULL
specifically	NULL
inhibits	NULL
IL-2-triggered	NULL
phosphorylation	NULL
of	NULL
STAT-3	NULL
,	NULL
STAT-5	NULL
,	NULL
and	NULL
extracellular	NULL
signal-related	NULL
kinase	NULL
(	NULL
ERK	NULL
)	NULL
1/2	NULL
,	NULL
and	NULL
IL-4-stimulated	NULL
phosphorylation	NULL
of	NULL
STAT-3	NULL
and	NULL
STAT-6	NULL
.	NULL

These	NULL
data	NULL
associate	NULL
y	NULL
,	NULL
cytokine	NULL
receptor	NULL
signaling	NULL
events	NULL
with	NULL
CD45	NULL
-regulated	NULL
intracellular	NULL
signaling	NULL
processes	NULL
in	NULL
lymphoblasts	NULL
and	NULL
again	NULL
highlight	NULL
the	NULL
dominant	NULL
role	NULL
for	NULL
CD45	NULL
in	NULL
influencing	NULL
early	NULL
cellular	NULL
activation	NULL
steps	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
preparation	NULL
PBMCs	NULL
were	NULL
isolated	NULL
from	NULL
heparinized	NULL
peripheral	NULL
blood	NULL
by	NULL
Ficoll-Hypaque	NULL
(	NULL
BAG	NULL
,	NULL
Lich	NULL
,	NULL
Germany	NULL
)	NULL
density	NULL
gradient	NULL
centrifugation	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Eg-genstein	NULL
,	NULL
Germany	NULL
)	NULL
supplemented	NULL
with	NULL
4	NULL
mM	NULL
L-glutamine	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
buffer	NULL
,	NULL
100	NULL
U/ml	NULL
penicillin	NULL
,	NULL
0.1	NULL
mg/ml	NULL
streptomycin	NULL
(	NULL
all	NULL
BioWhittaker	NULL
,	NULL
Verviers	NULL
,	NULL
Belgium	NULL
)	NULL
,	NULL
and	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
heat-inactivated	NULL
FCS	NULL
(	NULL
Life	NULL
Technolo-gies	NULL
)	NULL
.	NULL

For	NULL
generation	NULL
of	NULL
lymphoblasts	NULL
,	NULL
freshly	NULL
isolated	NULL
PBMCs	NULL
were	NULL
activated	NULL
with	NULL
1	NULL
pg/ml	NULL
PHA	NULL
(	NULL
Sigma	NULL
,	NULL
Deisenhofen	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
5	NULL
days	NULL
with	NULL
medium	NULL
being	NULL
replenished	NULL
every	NULL
2-3	NULL
days	NULL
.	NULL

Thereafter	NULL
,	NULL
cells	NULL
were	NULL
expanded	NULL
with	NULL
10	NULL
U/ml	NULL
IL-2	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
another	NULL
2-3	NULL
days	NULL
.	NULL

Resulting	NULL
lymphoblasts	NULL
were	NULL
>	NULL
95	NULL
%	NULL
CD3	NULL
*	NULL
(	NULL
with	NULL
60-80	NULL
%	NULL
CD4*	NULL
cells	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
lymphoblasts	NULL
were	NULL
extensively	NULL
washed	NULL
and	NULL
cultured	NULL
as	NULL
indicated	NULL
.	NULL

Abs	NULL
and	NULL
reagents	NULL
(	NULL
final	NULL
concentration	NULL
)	NULL
IL-2	NULL
(	NULL
10	NULL
U/ml	NULL
)	NULL
was	NULL
purchase	NULL
from	NULL
Boehringer	NULL
Mannheim	NULL
.	NULL

IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
IL-15	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
PeproTech	NULL
EC	NULL
(	NULL
London	NULL
,	NULL
U.K.	NULL
)	NULL
.	NULL

Hybridoma	NULL
cells	NULL
producing	NULL
CD3-mAb	NULL
OKT-3	NULL
(	NULL
IgG2a	NULL
,	NULL
1	NULL
pug/m	NULL
!	NULL
)	NULL

,	NULL
pan-CD45	NULL
mAb	NULL
NIH4S-2	NULL
(	NULL
IgGl	NULL
,	NULL
10	NULL
pg/ml	NULL
)	NULL
,	NULL
or	NULL
pan-CD45	NULL
mAb	NULL
GAP8.3	NULL
(	NULL
IgG2a	NULL
,	NULL
10	NULL
ug/ml	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
.	NULL

Hybridoma	NULL
cells	NULL
producing	NULL
CD45RO	NULL
mAb	NULL
UCHL-1	NULL
(	NULL
IgG2a	NULL
,	NULL
10	NULL
pg/ml	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Peter	NULL
Beverly	NULL
(	NULL
University	NULL
College	NULL
,	NULL
London	NULL
,	NULL
U.K.	NULL
)	NULL
.	NULL

mAbs	NULL
were	NULL
purified	NULL
from	NULL
hybridoma	NULL
cell	NULL
supernatant	NULL
with	NULL
the	NULL
fast	NULL
protein	NULL
liquid	NULL
chromatography	NULL
unit	NULL
LCC	NULL
500	NULL
plus	NULL
(	NULL
Pharmacia	NULL
,	NULL
Erlangen	NULL
,	NULL
Germany	NULL
)	NULL
using	NULL
HiTrap	NULL
protein	NULL
A-Sepharose	NULL
columns	NULL
from	NULL
Pharmacia	NULL
.	NULL

CD45RA	NULL
mAb	NULL
HB-11	NULL
(	NULL
IgG1	NULL
,	NULL
10	NULL
pg/ml	NULL
)	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
J.	NULL
Byme	NULL
(	NULL
University	NULL
of	NULL
Alabama	NULL
,	NULL
Birmingham	NULL
,	NULL
AL	NULL
)	NULL
.	NULL

CD2	NULL
mAbs	NULL
AICD2.M1	NULL
and	NULL
M2	NULL
(	NULL
1	NULL
pg/m	NULL
!	NULL
)	NULL

were	NULL
a	NULL
generous	NULL
gift	NULL
B.	NULL
Schraven	NULL
and	NULL
S.	NULL
Meuer	NULL
(	NULL
University	NULL
of	NULL
Heidelberg	NULL
,	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Staphylococcal	NULL
enterotoxin	NULL
B	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

pERK-1/2	NULL
mAb	NULL
(	NULL
E4	NULL
)	NULL
and	NULL
ERK	NULL
mAb	NULL
(	NULL
K-23	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Hei-delberg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

pSTAT-3	NULL
,	NULL
pSTAT-5	NULL
,	NULL
and	NULL
STAT-5	NULL
mAbs	NULL
were	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

pSTAT-6	NULL
was	NULL
purchased	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
(	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

mAbs	NULL
recognizing	NULL
STAT-3	NULL
and	NULL
STAT-6	NULL
were	NULL
obtained	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
.	NULL

6035	NULL
Quantification	NULL
of	NULL
apoptosis	NULL
Microscopic	NULL
examination	NULL
of	NULL
the	NULL
cell	NULL
cultures	NULL
prone	NULL
to	NULL
undergo	NULL
apoptosis	NULL
revealed	NULL
morphological	NULL
changes	NULL
like	NULL
zeiosis	NULL
.	NULL

For	NULL
quantification	NULL
of	NULL
apoptosis	NULL
,	NULL
DNA	NULL
staining	NULL
with	NULL
propidium	NULL
iodide	NULL
(	NULL
PI	NULL
;	NULL
Sigma	NULL
)	NULL
and	NULL
flow	NULL
cytometry	NULL
analysis	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
39	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
4	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
pelleted	NULL
with	NULL
200	NULL
X	NULL
g	NULL
and	NULL
gently	NULL
resuspended	NULL
in	NULL
150	NULL
ul	NULL
of	NULL
hypotonic	NULL
fluorochrome	NULL
solution	NULL
of	NULL
50	NULL
ug/ml	NULL
PI	NULL
in	NULL
0.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
sodium	NULL
citrate	NULL
plus	NULL
0.1	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
Triton	NULL
X-100	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

After	NULL
a	NULL
minimum	NULL
period	NULL
of	NULL
6	NULL
h	NULL
in	NULL
the	NULL
dark	NULL
at	NULL
4°C	NULL
,	NULL
samples	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
FACScan	NULL
(	NULL
Coulter	NULL
,	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
apoptotic	NULL
cells	NULL
was	NULL
calculated	NULL
as	NULL
follows	NULL
:	NULL
percentage	NULL
of	NULL
cells	NULL
with	NULL
subdiploid	NULL
DNA	NULL
content	NULL
X	NULL
100	NULL
divided	NULL
by	NULL
percentage	NULL
of	NULL
all	NULL
cells	NULL
positive	NULL
for	NULL
PI	NULL
staining	NULL
.	NULL

Cell	NULL
proliferation	NULL
assays	NULL
[	NULL
?	NULL

HJThymidine	NULL
uptake	NULL
and	NULL
incorporation	NULL
into	NULL
genomic	NULL
DNA	NULL
was	NULL
used	NULL
to	NULL
quantify	NULL
cellular	NULL
proliferation	NULL
.	NULL

PHA	NULL
blasts	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
72	NULL
h	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
150	NULL
ul	NULL
of	NULL
medium	NULL
in	NULL
a	NULL
96-well	NULL
round-bottom	NULL
microtiter	NULL
plate	NULL
(	NULL
Costar	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
with	NULL
the	NULL
indicated	NULL
reagents	NULL
in	NULL
triplicates	NULL
at	NULL
37°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
.	NULL

Samples	NULL
were	NULL
pulsed	NULL
for	NULL
the	NULL
last	NULL
6	NULL
h	NULL
with	NULL
0.5	NULL
uCi/well	NULL
[	NULL
H	NULL
]	NULL
thymidine	NULL
(	NULL
2	NULL
Ci/mmol	NULL
;	NULL
Amersham	NULL
,	NULL
Braunschweig	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
harvested	NULL
onto	NULL
glass	NULL
fiber	NULL
filters	NULL
.	NULL

Radioactivity	NULL
was	NULL
measured	NULL
by	NULL
liquid	NULL
scintillation	NULL
counting	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
IL-2-expanded	NULL
PHA	NULL
blasts	NULL
were	NULL
extensively	NULL
washed	NULL
and	NULL
aliquots	NULL
of	NULL
1	NULL
%	NULL
10°	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
8	NULL
h	NULL
in	NULL
medium	NULL
.	NULL

Thereafter	NULL
,	NULL
UCHL-1	NULL
mAb	NULL
was	NULL
added	NULL
for	NULL
10	NULL
min	NULL
before	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
or	NULL
OKT-3	NULL
were	NULL
pipetted	NULL
to	NULL
culture	NULL
medium	NULL
as	NULL
indicated	NULL
.	NULL

After	NULL
another	NULL
10-20	NULL
min	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
radio-immunoprecipitation	NULL
assay	NULL
lysis	NULL
buffer	NULL
containing	NULL
50	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.6	NULL
)	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
Triton	NULL
X-100	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
vanadate	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
10	NULL
pg/ml	NULL
aprotinin	NULL
,	NULL
10	NULL
ug/ml	NULL
pepstatin	NULL
,	NULL
10	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
and	NULL
0.25	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
at	NULL
4°C	NULL
for	NULL
1	NULL
h	NULL
(	NULL
all	NULL
reagents	NULL
from	NULL
Sigma	NULL
)	NULL
Supernatants	NULL
were	NULL
clarified	NULL
by	NULL
centrifugation	NULL
for	NULL
10	NULL
min	NULL
at	NULL
10,000	NULL
X	NULL
g	NULL
at	NULL
4°C	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
Bradford	NULL
method	NULL
protein	NULL
assay	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Twenty	NULL
micrograms	NULL
of	NULL
total	NULL
protein	NULL
lysates	NULL
from	NULL
each	NULL
sample	NULL
was	NULL
diluted	NULL
in	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
2X	NULL
SDS	NULL
sample	NULL
buffer	NULL
,	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
,	NULL
and	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Immunoblots	NULL
were	NULL
performed	NULL
by	NULL
semidry	NULL
transfer	NULL
from	NULL
the	NULL
proteins	NULL
onto	NULL
nitrocellulose	NULL
membranes	NULL
.	NULL

Unspecific	NULL
binding	NULL
sites	NULL
were	NULL
blocked	NULL
in	NULL
freshly	NULL
prepared	NULL
5	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
in	NULL
PBS/0.1	NULL
%	NULL
Tween	NULL
20	NULL
for	NULL
at	NULL
least	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

A	NULL
total	NULL
of	NULL
0.1-1	NULL
pg/ml	NULL
of	NULL
the	NULL
specific	NULL
Ab	NULL
as	NULL
indicated	NULL
was	NULL
incubated	NULL
in	NULL
blocking	NULL
buffer	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

Subsequently	NULL
,	NULL
0.2-1	NULL
pg/ml	NULL
HRP-conjugated	NULL
goat	NULL
anti-mouse	NULL
(	NULL
or	NULL
anti-rabbit	NULL
)	NULL
IgG	NULL
was	NULL
added	NULL
in	NULL
blocking	NULL
buffer	NULL
for	NULL
1.5	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Detection	NULL
was	NULL
performed	NULL
using	NULL
ECL	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

After	NULL
detection	NULL
of	NULL
phosphorylated	NULL
forms	NULL
of	NULL
proteins	NULL
,	NULL
Abs	NULL
were	NULL
washed	NULL
off	NULL
the	NULL
membranes	NULL
by	NULL
incubation	NULL
in	NULL
62.5	NULL
mM	NULL
NaCl	NULL
,	NULL
100	NULL
mM	NULL
2-ME	NULL
,	NULL
and	NULL
2	NULL
%	NULL
SDS	NULL
for	NULL
30	NULL
min	NULL
at	NULL
50-60°C	NULL
.	NULL

After	NULL
washing	NULL
in	NULL
PBS/0.1	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
membranes	NULL
were	NULL
blocked	NULL
as	NULL
described	NULL
above	NULL
,	NULL
and	NULL
staining	NULL
with	NULL
Abs	NULL
specific	NULL
for	NULL
all	NULL
forms	NULL
of	NULL
signaling	NULL
molecules	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
.	NULL

mRNA	NULL
semiquantification	NULL
by	NULL
RT-PCR	NULL
To	NULL
analyze	NULL
the	NULL
expression	NULL
of	NULL
apoptosis-related	NULL
gene	NULL
products	NULL
,	NULL
lymphoblasts	NULL
were	NULL
lysed	NULL
6-8	NULL
h	NULL
(	NULL
some	NULL
variation	NULL
in	NULL
between	NULL
the	NULL
experiments	NULL
)	NULL
after	NULL
stimulation	NULL
with	NULL
the	NULL
reagents	NULL
as	NULL
indicated	NULL
,	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
using	NULL
a	NULL
Qiagen	NULL
RNeasy	NULL
Mini	NULL
kit	NULL
(	NULL
Qiagen	NULL
,	NULL
Hilden	NULL
,	NULL
Germany	NULL
)	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

mRNA	NULL
purification	NULL
included	NULL
DNase	NULL
digestion	NULL
on	NULL
the	NULL
column	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
.	NULL

mRNA	NULL
was	NULL
reverse	NULL
transcribed	NULL
with	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
primers	NULL
and	NULL
amplified	NULL
with	NULL
gene-specific	NULL
primers	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
40	NULL
)	NULL
.	NULL

The	NULL
gene-specific	NULL
primers	NULL
(	NULL
all	NULL
intron	NULL
spanning	NULL
)	NULL
and	NULL
PCR	NULL
conditions	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
GAPDH	NULL
upstream	NULL
,	NULL
5'-GCAGGGGGGAGCCAAAAGGG-3	NULL
'	NULL
;	NULL
downstream	NULL
,	NULL
5	NULL
``	NULL
-CCATGGACGGTCGGGGTCGCAGTTTC-3	NULL
'	NULL
(	NULL
60°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
)	NULL
;	NULL
IL-2	NULL
upstream	NULL
,	NULL
5-ATGTACAGGATGCAACTCCTG	NULL
TCTT-3	NULL
'	NULL
;	NULL
downstream	NULL
,	NULL
5'-GTTAGTGTTGAGATGATGCTTTGAC-3	NULL
'	NULL
(	NULL
60°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
)	NULL
;	NULL
IL-4	NULL
upstream	NULL
,	NULL
5'-ATGGGTCTCACC	NULL
TCCCAACTGCT-3	NULL
'	NULL
;	NULL
downstream	NULL
,	NULL
TCTCAT-3	NULL
'	NULL
(	NULL
60°C	NULL
for	NULL
3	NULL
min	NULL
)	NULL
;	NULL
IL-5	NULL
upstream	NULL
,	NULL
GAGTTTGCTAGCT-3	NULL
'	NULL
;	NULL
downstream	NULL
,	NULL
5-TGGCCGTCAATGTATTITTCIT	NULL
TATTAAG-3	NULL
'	NULL
(	NULL
60°C	NULL
for	NULL
3	NULL
min	NULL
)	NULL
;	NULL
IL-12	NULL
(	NULL
40-kDa	NULL
)	NULL
upstream	NULL
,	NULL
5	NULL
``	NULL
-TAATCG	NULL
TCCAAAAGTGTTA-3	NULL
'	NULL
;	NULL
-	NULL
downstream	NULL
,	NULL
_	NULL
5	NULL
``	NULL
-TTCTGTTCTGCTGTGTCT	NULL
TG-3	NULL
'	NULL
(	NULL
60°C	NULL
for	NULL
3	NULL
min	NULL
)	NULL
,	NULL
IL-13	NULL
upstream	NULL
,	NULL
5'-ATCACCCAGAACCAGA	NULL
AG-3	NULL
'	NULL
;	NULL
downstream	NULL
,	NULL
5-GAACCGTCCCTCGCGAAAAAGT-3	NULL
'	NULL
(	NULL
60°C	NULL
for	NULL
1min	NULL
,	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
)	NULL
;	NULL
TNF-a	NULL
«	NULL
upstream	NULL
,	NULL
5	NULL
-ATGAGCACTGAAAGCATGA	NULL
TCCGG-3	NULL
'	NULL
;	NULL
downstream	NULL
,	NULL
5-GCAATGATCCCAAAGTAGACCTGCCC-3	NULL
'	NULL
(	NULL
60°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
)	NULL
;	NULL
IFN-y	NULL
upstream	NULL
,	NULL
5'-ATGAAATATA	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6036	NULL
CAAGTTATATCTTGGCTIT-3	NULL
'	NULL
;	NULL
|	NULL
downstream	NULL
,	NULL
-	NULL
5'-GATGCTCTITCGAC	NULL
CTCGAAACAGCAT-3	NULL
'	NULL
(	NULL
60°C	NULL
for	NULL
3	NULL
min	NULL
)	NULL
;	NULL
TNFR	NULL
p60	NULL
upstream	NULL
,	NULL
5'-	NULL
TGT	NULL
GTCTCCTGTAGTAACTG-3	NULL
'	NULL
;	NULL
downstream	NULL
,	NULL
5'-ACGAATTCCTITTCCAG	NULL
CGCAA-3	NULL
``	NULL
(	NULL
60°C	NULL
for	NULL
1min	NULL
)	NULL
,	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
)	NULL
;	NULL
TNFR	NULL
p80	NULL
upstream	NULL
,	NULL
5'-AAGTCCCTGACTCTGTGTGA-3	NULL
'	NULL
;	NULL
and	NULL
downstream	NULL
,	NULL
5	NULL
``	NULL
-TCCTGAGTCAA	NULL
CTTGAAGGA-3	NULL
'	NULL
(	NULL
60°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
)	NULL
.	NULL

cDNA	NULL
was	NULL
amplified	NULL
for	NULL
28	NULL
and	NULL
35	NULL
cycles	NULL
(	NULL
21	NULL
and	NULL
28	NULL
cycles	NULL
for	NULL
GAPDH	NULL
)	NULL
.	NULL

After	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
,	NULL
PCR	NULL
products	NULL
were	NULL
visualized	NULL
under	NULL
UV	NULL
light	NULL
,	NULL
and	NULL
band	NULL
intensities	NULL
of	NULL
the	NULL
corresponding	NULL
cycles	NULL
were	NULL
graded	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Measurement	NULL
of	NULL
cytokines	NULL
in	NULL
culture	NULL
supernatants	NULL
Cytokines	NULL
in	NULL
culture	NULL
supernatants	NULL
were	NULL
measured	NULL
using	NULL
ELISA	NULL
kits	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
(	NULL
for	NULL
IL-5	NULL
,	NULL
IFN-y	NULL
,	NULL
and	NULL
TNF-a	NULL
;	NULL
Wiesbaden	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

For	NULL
measurement	NULL
of	NULL
IL-2	NULL
,	NULL
we	NULL
used	NULL
capture	NULL
anti-IL-2	NULL
Ab	NULL
MAB602	NULL
and	NULL
biotin-linked	NULL
detection	NULL
Ab	NULL
BAF202	NULL
(	NULL
both	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
along	NULL
with	NULL
streptavidin-peroxidase	NULL
and	NULL
peroxidase	NULL
substrate	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
.	NULL

Quantification	NULL
of	NULL
IL-4	NULL
was	NULL
performed	NULL
with	NULL
capture	NULL
anti-IL-4	NULL
Ab	NULL
8D4-8	NULL
and	NULL
biotin-linked	NULL
detection	NULL
Ab	NULL
MP4-25D2	NULL
(	NULL
both	NULL
from	NULL
PharMingen	NULL
,	NULL
Hamburg	NULL
,	NULL
Germany	NULL
)	NULL
along	NULL
with	NULL
streptavidin-peroxidase	NULL
and	NULL
peroxidase	NULL
substrate	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
.	NULL

Statistical	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
paired	NULL
or	NULL
unpaired	NULL
(	NULL
where	NULL
appropriate	NULL
)	NULL
nonparametric	NULL
Wilcoxon	NULL
test	NULL
.	NULL

Results	NULL
In	NULL
freshly	NULL
isolated	NULL
PBMCs	NULL
,	NULL
pan-CD45	NULL
mAbs	NULL
NIH4S5-2	NULL
and	NULL
GAP8.3	NULL
as	NULL
well	NULL
as	NULL
CD45RO	NULL
mAb	NULL
UCHL-1	NULL
,	NULL
but	NULL
not	NULL
CD45RA	NULL
mAb	NULL
HB11	NULL
,	NULL
strongly	NULL
inhibited	NULL
cellular	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
various	NULL
stimuli	NULL
like	NULL
CD3	NULL
mAb	NULL
OKT-3	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
superantigen	NULL
staphylococcal	NULL
enterotoxin	NULL
B	NULL
,	NULL
or	NULL
CD2	NULL
mAbs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
all	NULL
of	NULL
these	NULL
mAbs	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
HB11	NULL
bind	NULL
to	NULL
CD45	NULL
epitopes	NULL
with	NULL
signaling	NULL
capacities	NULL
.	NULL

To	NULL
study	NULL
the	NULL
influence	NULL
of	NULL
CD45	NULL
signals	NULL
on	NULL
activated	NULL
human	NULL
lymphocytes	NULL
,	NULL
we	NULL
generated	NULL
lymphoblasts	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

These	NULL
cells	NULL
will	NULL
readily	NULL
proliferate	NULL
specifically	NULL
after	NULL
activation	NULL
with	NULL
y	NULL
,	NULL
,	NULL
cytokines	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
or	NULL
IL-15	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cytokine	NULL
withdrawal	NULL
induces	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Incubation	NULL
with	NULL
pan-CD45	NULL
BA	NULL
nedium	NULL
OKT-3	NULL
77A	NULL
OKT-3	NULL
+	NULL
NIH4S-2	NULL
C	NULL
1	NULL
OKT-3	NULL
+	NULL
GAP8.3	NULL
C	NULL
&	NULL
-3	NULL
OKT-3	NULL
+	NULL
UCHL-1	NULL
E	NULL
OKT-3	NULL
+	NULL
HBI11	NULL
AN	NULL
25000	NULL
20000	NULL
15000	NULL
10000	NULL
3y	NULL
-Thymidine	NULL
uptake	NULL
[	NULL
cpm	NULL
]	NULL
5000	NULL
0	NULL
FIGURE	NULL
1	NULL
.	NULL

CD45	NULL
mAbs	NULL
inhibit	NULL
proliferation	NULL
in	NULL
quiescent	NULL
PBMCs	NULL
.	NULL

PBMCs	NULL
were	NULL
isolated	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

One	NULL
X	NULL
10°	NULL
cells/well	NULL
were	NULL
stimulated	NULL
with	NULL
the	NULL
reagents	NULL
as	NULL
indicated	NULL
in	NULL
triplicates	NULL
.	NULL

DNA	NULL
synthesis	NULL
was	NULL
quantified	NULL
as	NULL
specified	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Numbers	NULL
are	NULL
mean	NULL
values	NULL
+	NULL
SD	NULL
of	NULL
10	NULL
different	NULL
experiments	NULL
.	NULL

CD45	NULL
mAbs	NULL
alone	NULL
did	NULL
not	NULL
induce	NULL
proliferation	NULL
over	NULL
background	NULL
levels	NULL
.	NULL

CD45	NULL
CONTROLS	NULL
STAT	NULL
AND	NULL
ERK	NULL
PHOSPHORYLATION	NULL
medium	NULL
mm	NULL
UCHL-1	NULL
NY	NULL
GAP8.3	NULL
70000	NULL
60000	NULL
50000	NULL
40000	NULL
30000	NULL
proliferation	NULL
[	NULL
¢pm|	NULL
]	NULL
20000	NULL
10000	NULL
FIGURE	NULL
2	NULL
.	NULL

CD45RO	NULL
mAb	NULL
UCHL-1	NULL
inhibits	NULL
y	NULL
,	NULL
cytokine-driven	NULL
proliferation	NULL
of	NULL
lymphoblasts	NULL
.	NULL

Lymphoblasts	NULL
were	NULL
generated	NULL
as	NULL
described	NULL
.	NULL

One	NULL
X	NULL
10°	NULL
cells/well	NULL
were	NULL
stimulated	NULL
with	NULL
the	NULL
reagents	NULL
as	NULL
indicated	NULL
in	NULL
triplicates	NULL
.	NULL

DNA	NULL
synthesis	NULL
was	NULL
quantified	NULL
as	NULL
specified	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Numbers	NULL
are	NULL
mean	NULL
values	NULL
+	NULL
SD	NULL
of	NULL
10	NULL
different	NULL
experiments	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
,	NULL
comparing	NULL
incorporation	NULL
in	NULL
medium	NULL
vs	NULL
UCHL-1	NULL
mAb-containing	NULL
wells	NULL
within	NULL
each	NULL
experimental	NULL
setting	NULL
.	NULL

mAbs	NULL
NIH4S-2	NULL
,	NULL
GAP8.3	NULL
,	NULL
or	NULL
CD45RO	NULL
mAb	NULL
UCHL-1	NULL
alone	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
proliferation	NULL
.	NULL

Importantly	NULL
,	NULL
however	NULL
,	NULL
UCHL-1	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
GAP8.3	NULL
or	NULL
NIH4S-2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
significantly	NULL
inhibited	NULL
proliferation	NULL
triggered	NULL
by	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
or	NULL
IL-15	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
stimulation	NULL
of	NULL
lymphoblasts	NULL
with	NULL
CD3	NULL
mAb	NULL
OKT-3	NULL
alone	NULL
did	NULL
not	NULL
trigger	NULL
proliferation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
however	NULL
,	NULL
cosignaling	NULL
through	NULL
CD3	NULL
and	NULL
CD4SRO	NULL
diminished	NULL
UCHL-1-mediated	NULL
inhibition	NULL
of	NULL
IL-4-	NULL
or	NULL
IL-7-triggered	NULL
proliferation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
whereas	NULL
IL-2-	NULL
and	NULL
IL-15-dependent	NULL
DNA	NULL
synthesis	NULL
was	NULL
practically	NULL
unaffected	NULL
by	NULL
OKT-3	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

This	NULL
pattern	NULL
held	NULL
through	NULL
for	NULL
all	NULL
concentrations	NULL
of	NULL
cytokines	NULL
tested	NULL
(	NULL
1-10	NULL
U/ml	NULL
or	NULL
ng/ml	NULL
,	NULL
respec-tively	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
lymphoblasts	NULL
are	NULL
prone	NULL
to	NULL
undergo	NULL
apoptosis	NULL
upon	NULL
various	NULL
stimuli	NULL
,	NULL
especially	NULL
those	NULL
limiting	NULL
proliferation	NULL
,	NULL
we	NULL
wondered	NULL
whether	NULL
this	NULL
UCHL-1-mediated	NULL
inhibition	NULL
of	NULL
proliferation	NULL
consequently	NULL
induced	NULL
apoptosis	NULL
,	NULL
or	NULL
vice	NULL
versa	NULL
was	NULL
the	NULL
effect	NULL
of	NULL
increased	NULL
apoptosis	NULL
as	NULL
seen	NULL
after	NULL
cytokine	NULL
withdrawal	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
we	NULL
compared	NULL
percentages	NULL
of	NULL
apoptosis	NULL
under	NULL
various	NULL
concentrations	NULL
of	NULL
IL-2	NULL
or	NULL
IL-4	NULL
.	NULL

Table	NULL
I	NULL
shows	NULL
that	NULL
suboptimal	NULL
concentrations	NULL
of	NULL
IL-2	NULL
not	NULL
only	NULL
lead	NULL
to	NULL
decreased	NULL
DNA	NULL
synthesis	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
but	NULL
subsequently	NULL
also	NULL
to	NULL
increased	NULL
rates	NULL
of	NULL
apoptosis	NULL
.	NULL

Importantly	NULL
,	NULL
however	NULL
,	NULL
addition	NULL
of	NULL
UCHL-1	NULL
or	NULL
GAP8.3	NULL
did	NULL
not	NULL
induce	NULL
apoptosis	NULL
over	NULL
the	NULL
quantities	NULL
seen	NULL
in	NULL
cytokine-stimulated	NULL
lymphoblasts	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Abs	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
seen	NULL
when	NULL
we	NULL
tested	NULL
various	NULL
concentrations	NULL
of	NULL
IL-4	NULL
in	NULL
the	NULL
identical	NULL
experimental	NULL
setting	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

For	NULL
optimal	NULL
signal	NULL
transduction	NULL
after	NULL
y	NULL
,	NULL
cytokine	NULL
stimulation	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
activation	NULL
of	NULL
several	NULL
proteins	NULL
like	NULL
STAT-3	NULL
,	NULL
STAT-5	NULL
,	NULL
ERK1/2	NULL
,	NULL
or	NULL
STAT-6	NULL
(	NULL
IL-4	NULL
STAT	NULL
)	NULL
is	NULL
required	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

42	NULL
and	NULL
43	NULL
)	NULL
.	NULL

These	NULL
early	NULL
signaling	NULL
proteins	NULL
are	NULL
regulated	NULL
in	NULL
their	NULL
activity	NULL
via	NULL
tyrosine	NULL
phosphorylation	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
6037	NULL
Table	NULL
I	NULL
.	NULL

-	NULL
Percentage	NULL
of	NULL
apoptotic	NULL
lymphoblasts	NULL
after	NULL
CD45	NULL
signaling	NULL
``	NULL
IL-2	NULL
Medium	NULL
1	NULL
U/ml	NULL
2	NULL
U/ml	NULL
4	NULL
U/ml	NULL
8	NULL
U/ml	NULL
10	NULL
U/ml	NULL
Medium	NULL
24.2	NULL
+	NULL
2.5	NULL
21.8	NULL
+	NULL
2.4	NULL
19.5	NULL
+	NULL
1.9	NULL
15.1	NULL
+	NULL
1.0	NULL
12.9	NULL
£	NULL
1.7	NULL
12.5	NULL
+	NULL
1.8	NULL
UCHL-1	NULL
25.5	NULL
+	NULL
2.3	NULL
22.5	NULL
£	NULL
1.9	NULL
17.5	NULL
+	NULL
2.1	NULL
14.0	NULL
+	NULL
1.1	NULL
11.5	NULL
+	NULL
2.0	NULL
9.5	NULL
+	NULL
1.7	NULL
GAP8.3	NULL
25.1	NULL
+	NULL
2.0	NULL
20.5	NULL
+-	NULL
1.8	NULL
17.6	NULL
+	NULL
1.8	NULL
15.5	NULL
+	NULL
1.2	NULL
13.5	NULL
+	NULL
1.9	NULL
11.5	NULL
+	NULL
1.4	NULL
*	NULL
Cytokine	NULL
withdrawal	NULL
induces	NULL
apoptosis	NULL
,	NULL
which	NULL
is	NULL
not	NULL
further	NULL
augmented	NULL
by	NULL
CD45	NULL
signals	NULL
.	NULL

Lymphoblasts	NULL
were	NULL
generated	NULL
as	NULL
described	NULL
.	NULL

Four	NULL
X	NULL
10°	NULL
cells/well	NULL
were	NULL
incubated	NULL
for	NULL
3	NULL
days	NULL
with	NULL
the	NULL
reagents	NULL
as	NULL
indicated	NULL
.	NULL

Apoptosis	NULL
was	NULL
quantified	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Numbers	NULL
show	NULL
mean	NULL
percentages	NULL
of	NULL
apoptotic	NULL
cells	NULL
+	NULL
SD	NULL
and	NULL
stem	NULL
from	NULL
three	NULL
different	NULL
experiments	NULL
.	NULL

(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
based	NULL
on	NULL
the	NULL
results	NULL
as	NULL
demonstrated	NULL
,	NULL
it	NULL
was	NULL
tempting	NULL
to	NULL
hypothesize	NULL
that	NULL
CD45	NULL
phosphotyrosine	NULL
phosphatase	NULL
interferes	NULL
with	NULL
these	NULL
phosphorylation	NULL
processes	NULL
,	NULL
thereby	NULL
limiting	NULL
cellular	NULL
activation	NULL
through	NULL
cytokine	NULL
signals	NULL
.	NULL

To	NULL
test	NULL
this	NULL
,	NULL
we	NULL
performed	NULL
Western	NULL
blots	NULL
,	NULL
staining	NULL
with	NULL
Abs	NULL
recognizing	NULL
the	NULL
ty-rosine-phosphorylated	NULL
forms	NULL
of	NULL
STAT-3	NULL
,	NULL
STAT-5	NULL
,	NULL
STAT-6	NULL
,	NULL
or	NULL
ERK1/2	NULL
.	NULL

As	NULL
control	NULL
for	NULL
equal	NULL
protein	NULL
loading	NULL
,	NULL
we	NULL
used	NULL
Abs	NULL
detecting	NULL
all	NULL
forms	NULL
of	NULL
the	NULL
respective	NULL
protein	NULL
after	NULL
stripping	NULL
of	NULL
the	NULL
identical	NULL
membranes	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
compared	NULL
with	NULL
cells	NULL
kept	NULL
in	NULL
medium	NULL
(	NULL
Zanes	NULL
1-3	NULL
)	NULL
,	NULL
IL-2	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT-3	NULL
,	NULL
STAT-5	NULL
,	NULL
and	NULL
ERK	NULL
1/2	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
whereas	NULL
IL-4	NULL
led	NULL
to	NULL
phosphorylation	NULL
of	NULL
STAT-3	NULL
and	NULL
STAT-6	NULL
(	NULL
Zane	NULL
7	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
however	NULL
,	NULL
addition	NULL
of	NULL
the	NULL
CD45RO	NULL
mAb	NULL
UCHL-1	NULL
or	NULL
the	NULL
pan-CD45	NULL
mAb	NULL
GAP8.3	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
was	NULL
ineffective	NULL
alone	NULL
.	NULL

UCHL-1	NULL
strongly	NULL
diminished	NULL
IL-2-mediated	NULL
phosphorylation	NULL
of	NULL
STAT-3	NULL
,	NULL
STAT-5	NULL
,	NULL
and	NULL
ERK1/2	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
and	NULL
IL-4	NULL
induced	NULL
phosphorylation	NULL
of	NULL
STAT-3	NULL
and	NULL
STAT-6	NULL
after	NULL
IL-4	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

Control	NULL
mAb	NULL
GAPS8.3	NULL
did	NULL
not	NULL
significantly	NULL
influence	NULL
STAT	NULL
or	NULL
ERK	NULL
phosphorylation	NULL
under	NULL
these	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
after	NULL
stripping	NULL
of	NULL
the	NULL
membranes	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
staining	NULL
with	NULL
STAT	NULL
or	NULL
ERK	NULL
Abs	NULL
recognizing	NULL
all	NULL
forms	NULL
of	NULL
these	NULL
intracellular	NULL
signaling	NULL
molecules	NULL
revealed	NULL
equal	NULL
protein	NULL
loading	NULL
in	NULL
each	NULL
lane	NULL
(	NULL
with	NULL
some	NULL
lower	NULL
protein	NULL
content	NULL
in	NULL
the	NULL
STAT-3	NULL
blot	NULL
in	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

Stimulation	NULL
:	NULL
med	NULL
IL-2	NULL
IL-4	NULL
med	NULL
lUCI—ILll	NULL
Gap	NULL
|	NULL
med	NULL
|UCHL1|	NULL
Gap	NULL
|	NULL
med	NULL
lUCHL1|	NULL
Gap	NULL
Detection	NULL
:	NULL
;	NULL
P-STAT3	NULL
STAT3	NULL
P-STATS5	NULL
STATS	NULL
--	NULL
--	NULL
-	NULL
|	NULL
P-STAT6	NULL
STAT6	NULL
waa	NULL
)	NULL
_	NULL
P-ERK	NULL
ERK-1	NULL
FIGURE	NULL
3	NULL
.	NULL

CD45RO	NULL
signals	NULL
influence	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
and	NULL
ERK1/2	NULL
molecules	NULL
.	NULL

Lymphoblasts	NULL
were	NULL
generated	NULL
as	NULL
described	NULL
.	NULL

After	NULL
8	NULL
h	NULL
of	NULL
cytokine	NULL
deprivation	NULL
,	NULL
UCHL-1	NULL
or	NULL
GAP8.3	NULL
(	NULL
Gap	NULL
)	NULL
mAb	NULL
was	NULL
added	NULL
as	NULL
specified	NULL
.	NULL

After	NULL
10	NULL
min	NULL
,	NULL
IL-2	NULL
or	NULL
IL-4	NULL
was	NULL
pipetted	NULL
to	NULL
culture	NULL
medium	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
lysed	NULL
after	NULL
another	NULL
10-20	NULL
min	NULL
.	NULL

Western	NULL
blots	NULL
for	NULL
phosphorylated	NULL
STATs	NULL
or	NULL
ERK1/2	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Thereafter	NULL
,	NULL
membranes	NULL
were	NULL
stripped	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
mAbs	NULL
recognizing	NULL
all	NULL
forms	NULL
of	NULL
STATs	NULL
or	NULL
ERK1/2	NULL
.	NULL

The	NULL
experiment	NULL
shown	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
different	NULL
experiments	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
CD4SRO	NULL
signals	NULL
not	NULL
only	NULL
influenced	NULL
DNA	NULL
synthesis	NULL
and	NULL
early	NULL
intracellular	NULL
cytokine	NULL
signaling	NULL
,	NULL
but	NULL
could	NULL
also	NULL
change	NULL
mRNA	NULL
production	NULL
after	NULL
IL-2	NULL
or	NULL
IL-4	NULL
stim-ulation	NULL
.	NULL

Fig	NULL
.	NULL

4	NULL
denotes	NULL
that	NULL
stimulation	NULL
of	NULL
lymphoblasts	NULL
with	NULL
IL-2	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
specifically	NULL
led	NULL
to	NULL
increased	NULL
IL-13	NULL
mRNA	NULL
synthesis	NULL
,	NULL
with	NULL
no	NULL
effects	NULL
on	NULL
IL-2	NULL
,	NULL
TNF-a	NULL
,	NULL
IFN-y	NULL
,	NULL
or	NULL
IL-5	NULL
mRNA	NULL
.	NULL

IL-4	NULL
was	NULL
not	NULL
effective	NULL
in	NULL
inducing	NULL
mRNA	NULL
synthesis	NULL
over	NULL
the	NULL
background	NULL
level	NULL
.	NULL

Interestingly	NULL
,	NULL
under	NULL
costimulation	NULL
with	NULL
IL-2	NULL
or	NULL
IL-4	NULL
,	NULL
UCHL-1	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
8	NULL
)	NULL
,	NULL
but	NULL
not	NULL
GAPS.3	NULL
signaling	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
9	NULL
)	NULL
alone	NULL
could	NULL
consistently	NULL
diminish	NULL
IL-2	NULL
mRNA	NULL
quantities	NULL
at	NULL
least	NULL
4-fold	NULL
(	NULL
semiquantified	NULL
as	NULL
described	NULL
by	NULL
Lagoo-Deenadayalan	NULL
et	NULL
al	NULL
.	NULL

(	NULL
40	NULL
)	NULL
)	NULL
.	NULL

This	NULL
was	NULL
also	NULL
seen	NULL
in	NULL
many	NULL
,	NULL
but	NULL
not	NULL
all	NULL
lymphoblasts	NULL
only	NULL
stimulated	NULL
with	NULL
UCHL-1	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
coactivation	NULL
through	NULL
UCHL-1	NULL
and	NULL
IL-2	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
GAP8.3	NULL
and	NULL
IL-2	NULL
,	NULL
but	NULL
not	NULL
Ab	NULL
combinations	NULL
along	NULL
with	NULL
IL-4	NULL
,	NULL
increased	NULL
TNF-a	NULL
mRNA	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
3-6	NULL
and	NULL
7-9	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
influence	NULL
of	NULL
the	NULL
various	NULL
stimuli	NULL
on	NULL
mRNA	NULL
expression	NULL
of	NULL
IL-4	NULL
,	NULL
TNF-	NULL
«	NULL
receptors	NULL
p60	NULL
and	NULL
p80	NULL
,	NULL
and	NULL
IL-12	NULL
.	NULL

IL-4	NULL
and	NULL
TNF-a	NULL
receptor	NULL
p80	NULL
mRNA	NULL
levels	NULL
were	NULL
unaffected	NULL
,	NULL
whereas	NULL
we	NULL
could	NULL
not	NULL
detect	NULL
IL-12	NULL
or	NULL
TNF-a	NULL
receptor	NULL
p60	NULL
mRNA	NULL
in	NULL
lymphoblasts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

G	NULL
ke	NULL
!	NULL

kel	NULL
O	NULL
3	NULL
3	NULL
$	NULL
$	NULL
§	NULL
6	NULL
f	NULL
S	NULL
$	NULL
CAaTOH	NULL
IL-2	NULL
TNF-a	NULL
IFN-y	NULL
IL_5	NULL
—	NULL
FIGURE	NULL
4	NULL
.	NULL

-	NULL
Influence	NULL
of	NULL
CD45	NULL
signals	NULL
on	NULL
mRNA	NULL
quantities	NULL
in	NULL
lymphoblasts	NULL
.	NULL

Lymphoblasts	NULL
were	NULL
generated	NULL
as	NULL
described	NULL
.	NULL

After	NULL
stimulation	NULL
under	NULL
the	NULL
various	NULL
conditions	NULL
as	NULL
specified	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
,	NULL
RNA	NULL
isolated	NULL
,	NULL
mRNA	NULL
reverse	NULL
transcribed	NULL
,	NULL
and	NULL
amplified	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
different	NULL
experiments	NULL
after	NULL
PCR	NULL
amplification	NULL
for	NULL
28	NULL
cycles	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6038	NULL
1100	NULL
1000	NULL
-	NULL
BR	NULL
medium	NULL
C-_-_J	NULL
UCHL-1	NULL
GSH	NULL
GAP8.3	NULL
900	NULL
800	NULL
<	NULL
ax	NULL
:	NULL
Sd	NULL
<	NULL
sx	NULL
SS	NULL
700	NULL
e	NULL
sas	NULL
ates	NULL
<	NULL
yx	NULL
date	NULL
600	NULL
e	NULL
SSS	NULL
yx	NULL
e	NULL
e	NULL
2x	NULL
500	NULL
Xe	NULL
IFN-¥	NULL
[	NULL
pg/tal	NULL
]	NULL
ox	NULL
etetete	NULL
<	NULL
yx	NULL
date	NULL
400	NULL
<	NULL
&	NULL
ay	NULL
SS	NULL
ys	NULL
mete	NULL
300	NULL
<	NULL
e	NULL
i	NULL
%	NULL
ys	NULL
:	NULL
C	NULL
O	NULL
200	NULL
xy	NULL
s	NULL
<	NULL
xx	NULL
S	NULL
C	NULL
100	NULL
yx	NULL
SS	NULL
Re	NULL
xx	NULL
SS	NULL
C	NULL
p	NULL
res	NULL
(	NULL
xX	NULL
+	NULL
OKT-3	NULL
FIGURE	NULL
5	NULL
.	NULL

Influence	NULL
of	NULL
CD45	NULL
signals	NULL
on	NULL
IFN-y	NULL
secretion	NULL
by	NULL
lymphoblasts	NULL
.	NULL

Lymphoblasts	NULL
were	NULL
generated	NULL
as	NULL
described	NULL
.	NULL

Sixteen	NULL
to	NULL
20	NULL
h	NULL
after	NULL
stimulation	NULL
under	NULL
the	NULL
various	NULL
conditions	NULL
as	NULL
specified	NULL
,	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
concentrations	NULL
of	NULL
IFN-y	NULL
were	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Data	NULL
are	NULL
mean	NULL
values	NULL
+	NULL
SD	NULL
from	NULL
three	NULL
different	NULL
experiments	NULL
.	NULL

Similarly	NULL
,	NULL
we	NULL
wondered	NULL
,	NULL
whether	NULL
these	NULL
changes	NULL
in	NULL
mRNA	NULL
production	NULL
were	NULL
also	NULL
reflected	NULL
in	NULL
alterations	NULL
of	NULL
protein	NULL
secretion	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
we	NULL
collected	NULL
supernatants	NULL
after	NULL
overnight	NULL
stimulation	NULL
of	NULL
lymphoblasts	NULL
under	NULL
identical	NULL
experimental	NULL
conditions	NULL
.	NULL

We	NULL
did	NULL
not	NULL
detect	NULL
IL-2	NULL
or	NULL
IL-4	NULL
in	NULL
any	NULL
supernatants	NULL
(	NULL
except	NULL
for	NULL
those	NULL
where	NULL
the	NULL
cytokines	NULL
had	NULL
been	NULL
added	NULL
exogenously	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Measurements	NULL
of	NULL
IFN-y	NULL
,	NULL
TNF-a	NULL
@	NULL
,	NULL
and	NULL
IL-5	NULL
concentrations	NULL
indicated	NULL
that	NULL
IL-2	NULL
,	NULL
but	NULL
not	NULL
IL-4	NULL
,	NULL
was	NULL
able	NULL
to	NULL
stimulate	NULL
secretion	NULL
of	NULL
the	NULL
cytokines	NULL
in	NULL
low	NULL
quantities	NULL
over	NULL
the	NULL
background	NULL
level	NULL
,	NULL
which	NULL
was	NULL
not	NULL
altered	NULL
by	NULL
signals	NULL
through	NULL
CD45	NULL
epitopes	NULL
recognized	NULL
by	NULL
UCHL-1	NULL
or	NULL
GAP8.3	NULL
(	NULL
Figs	NULL
.	NULL

5-7	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
after	NULL
activation	NULL
through	NULL
CD3	NULL
,	NULL
lymphoblasts	NULL
secreted	NULL
TNF-a	NULL
and	NULL
IFN-y	NULL
,	NULL
but	NULL
not	NULL
IL-5	NULL
,	NULL
in	NULL
quantities	NULL
comparable	NULL
to	NULL
the	NULL
IL-2	NULL
effects	NULL
(	NULL
Figs	NULL
.	NULL

5-7	NULL
)	NULL
.	NULL

Secretion	NULL
of	NULL
these	NULL
cytokines	NULL
was	NULL
again	NULL
not	NULL
significantly	NULL
influenced	NULL
by	NULL
CD45	NULL
cosig-naling	NULL
.	NULL

Costimulation	NULL
with	NULL
OKT-3	NULL
and	NULL
IL-2	NULL
,	NULL
but	NULL
not	NULL
OKT-3	NULL
and	NULL
IL-4	NULL
,	NULL
consistently	NULL
and	NULL
synergistically	NULL
induced	NULL
secretion	NULL
of	NULL
high	NULL
levels	NULL
of	NULL
TNF-a	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
and	NULL
especially	NULL
IL-5	NULL
and	NULL
IFN-y	NULL
(	NULL
Figs	NULL
.	NULL

5	NULL
and	NULL
7	NULL
)	NULL
,	NULL
which	NULL
was	NULL
again	NULL
not	NULL
diminished	NULL
by	NULL
€D45	NULL
signaling	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
role	NULL
of	NULL
CD45	NULL
signaling	NULL
in	NULL
activated	NULL
human	NULL
lymphoblasts	NULL
.	NULL

As	NULL
described	NULL
,	NULL
lymphoblasts	NULL
are	NULL
not	NULL
comparable	NULL
to	NULL
quiescent	NULL
lymphocytes	NULL
in	NULL
their	NULL
intracellular	NULL
signaling	NULL
responses	NULL
to	NULL
the	NULL
identical	NULL
stimuli	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Fas/Apo-1	NULL
stimulation	NULL
will	NULL
lead	NULL
to	NULL
apoptotic	NULL
cell	NULL
death	NULL
in	NULL
activated	NULL
cells	NULL
,	NULL
whereas	NULL
quiescent	NULL
lymphocytes	NULL
are	NULL
unresponsive	NULL
to	NULL
these	NULL
triggers	NULL
(	NULL
45	NULL
)	NULL
.	NULL

CD3	NULL
stimulation	NULL
in	NULL
quiescent	NULL
cells	NULL
leads	NULL
to	NULL
cellular	NULL
prolifer-ation	NULL
;	NULL
in	NULL
activated	NULL
cells	NULL
,	NULL
however	NULL
,	NULL
these	NULL
triggers	NULL
can	NULL
lead	NULL
to	NULL
apoptotic	NULL
cell	NULL
death	NULL
under	NULL
certain	NULL
circumstances	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Since	NULL
we	NULL
have	NULL
been	NULL
studying	NULL
intracellular	NULL
€D45	NULL
signaling	NULL
in	NULL
quiescent	NULL
PBMCs	NULL
in	NULL
the	NULL
past	NULL
(	NULL
3	NULL
,	NULL
37	NULL
,	NULL
38	NULL
)	NULL
,	NULL
we	NULL
were	NULL
interested	NULL
in	NULL
the	NULL
effects	NULL
of	NULL
these	NULL
stimuli	NULL
in	NULL
activated	NULL
lymphoblasts	NULL
.	NULL

We	NULL
herein	NULL
describe	NULL
that	NULL
signals	NULL
through	NULL
CD45RO	NULL
can	NULL
inhibit	NULL
proliferation	NULL
,	NULL
mRNA	NULL
synthesis	NULL
,	NULL
and	NULL
y	NULL
,	NULL
,	NULL
receptor-associated	NULL
signals	NULL
in	NULL
human	NULL
peripheral	NULL
nonlineage	NULL
lymphoblasts	NULL
.	NULL

However	NULL
and	NULL
im-	NULL
CD45	NULL
CONTROLS	NULL
STAT	NULL
AND	NULL
ERK	NULL
PHOSPHORYLATION	NULL
90	NULL
RHM	NULL
medium	NULL
C	NULL
--	NULL
J	NULL
UCHL-1	NULL
EXS	NULL
GAP8.3	NULL
80	NULL
70	NULL
ee	NULL
XS	NULL
x2	NULL
ews	NULL
tele	NULL
sx	NULL
date	NULL
%	NULL
yx	NULL
SS	NULL
60	NULL
*	NULL
o	NULL
xx	NULL
<	NULL
te	NULL
xx	NULL
techs	NULL
50	NULL
>	NULL
sx	NULL
S	NULL
C	NULL
sx	NULL
SSS	NULL
<	NULL
siete	NULL
5	NULL
fete	NULL
!	NULL

e	NULL
40	NULL
TNF-	NULL
``	NULL
[	NULL
pg/mI	NULL
]	NULL
x	NULL
fe	NULL
yx	NULL
e	NULL
e	NULL
X	NULL
co	NULL
e	NULL
x	NULL
30	NULL
xz	NULL
$	NULL
p	NULL
xz	NULL
$	NULL
65	NULL
t	NULL
an	NULL
XXX	NULL
to	NULL
XXXXXXXA	NULL
x	NULL
SC	NULL
CC	NULL
8d	NULL
20	NULL
XX	NULL
xz	NULL
$	NULL
e	NULL
2d	NULL
%	NULL
ax	NULL
%	NULL
x	NULL
Ad	NULL
xx	NULL
XS	NULL
z	NULL
%	NULL
XX	NULL
nee	NULL
SS	NULL
z	NULL
$	NULL
z	NULL
$	NULL
x	NULL
>	NULL
x	NULL
>	NULL
xx	NULL
oats	NULL
G	NULL
xx	NULL
H	NULL
XXx	NULL
OK	NULL
S	NULL
XX	NULL
>	NULL
SSE	NULL
x	NULL
>	NULL
ewer	NULL
Iefetets	NULL
b	NULL
C	NULL
<	NULL
SS	NULL
it	NULL
fete	NULL
!	NULL

*	NULL
x	NULL
23s	NULL
Ix	NULL
te	NULL
!	NULL

i	NULL
he	NULL
bexd	NULL
medium	NULL
IL-2	NULL
_	NULL
IL-122222222220	NULL
__	NULL
XX	NULL
h	NULL
medium	NULL
IL-2	NULL
_	NULL
IL-4	NULL
+	NULL
OKT-3	NULL
FIGURE	NULL
6	NULL
.	NULL

Influence	NULL
of	NULL
CD45	NULL
signals	NULL
on	NULL
TNF-a	NULL
secretion	NULL
by	NULL
lymphoblasts	NULL
.	NULL

Lymphoblasts	NULL
were	NULL
generated	NULL
as	NULL
described	NULL
.	NULL

Sixteen	NULL
to	NULL
20	NULL
h	NULL
after	NULL
stimulation	NULL
under	NULL
the	NULL
various	NULL
conditions	NULL
as	NULL
specified	NULL
,	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
concentrations	NULL
of	NULL
TNF-a	NULL
were	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Data	NULL
are	NULL
mean	NULL
values	NULL
+	NULL
SD	NULL
from	NULL
three	NULL
different	NULL
experiments	NULL
.	NULL

portantly	NULL
,	NULL
signals	NULL
through	NULL
the	NULL
epitopes	NULL
recognized	NULL
by	NULL
pan-CD45	NULL
mAb	NULL
GAP8.3	NULL
have	NULL
different	NULL
effects	NULL
in	NULL
lymphocytes	NULL
vs	NULL
lymphoblasts	NULL
:	NULL
in	NULL
quiescent	NULL
cells	NULL
this	NULL
mAb	NULL
is	NULL
most	NULL
effective	NULL
in	NULL
inhibiting	NULL
OKT	NULL
proliferation	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
whereas	NULL
it	NULL
served	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
mAb	NULL
in	NULL
our	NULL
experiments	NULL
with	NULL
lymphoblasts	NULL
,	NULL
not	NULL
influencing	NULL
y	NULL
,	NULL
-	NULL
and	NULL
OKT-3-induced	NULL
signals	NULL
.	NULL

These	NULL
data	NULL
argue	NULL
for	NULL
a	NULL
cell	NULL
cycle-dependent	NULL
function	NULL
of	NULL
certain	NULL
CD45	NULL
epitopes	NULL
in	NULL
human	NULL
180	NULL
1680	NULL
nediom	NULL
(	NULL
_-_	NULL
]	NULL
J	NULL
UCHL-1	NULL
SSH	NULL
GAP8.3	NULL
Ce	NULL
140	NULL
-	NULL
X	NULL
x	NULL
Rt	NULL
ts	NULL
&	NULL
4	NULL
120	NULL
-	NULL
ies	NULL
s	NULL
B	NULL
lite	NULL
-	NULL
t	NULL
=	NULL
;	NULL
s	NULL
100	NULL
-	NULL
iet	NULL
bst	NULL
P0004	NULL
sh	NULL
lete	NULL
S	NULL
;	NULL
8	NULL
-	NULL
&	NULL
4	NULL
``	NULL
,	NULL
80	NULL
-	NULL
os	NULL
foal	NULL
t	NULL
-	NULL
lete	NULL
BX	NULL
e	NULL
(	NULL
%	NULL
60	NULL
-	NULL
Es	NULL
ies	NULL
lete	NULL
&	NULL
ases	NULL
to	NULL
leve	NULL
hes	NULL
40	NULL
-	NULL
$	NULL
Red	NULL
he	NULL
SX	NULL
ese	NULL
Resd	NULL
e	NULL
XX	NULL
sd	NULL
RX	NULL
hew	NULL
IX	NULL
Kd	NULL
ISX	NULL
Re	NULL
ides	NULL
20	NULL
-	NULL
3	NULL
is	NULL
R	NULL
iges	NULL
lete	NULL
ieee	NULL
lete	NULL
io	NULL
afe	NULL
34	NULL
(	NULL
8	NULL
lets	NULL
]	NULL
ele	NULL
o	NULL
-	NULL
ic-sz	NULL
OG	NULL
I_	NULL
ka	NULL
i-A2	NULL
l	NULL
DO	NULL
:	NULL
medium	NULL
IL-2	NULL
-	NULL
IL-4	NULL
medium	NULL
IL-2	NULL
_	NULL
IL-4	NULL
s	NULL
+	NULL
OKT-3	NULL
FIGURE	NULL
7	NULL
.	NULL

Influence	NULL
of	NULL
CD45	NULL
signals	NULL
on	NULL
IL-5	NULL
secretion	NULL
by	NULL
lymphoblasts	NULL
.	NULL

Lymphoblasts	NULL
were	NULL
generated	NULL
as	NULL
described	NULL
.	NULL

Sixteen	NULL
to	NULL
20	NULL
h	NULL
after	NULL
stimulation	NULL
under	NULL
the	NULL
various	NULL
conditions	NULL
as	NULL
specified	NULL
,	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
concentrations	NULL
of	NULL
IL-5	NULL
were	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Data	NULL
are	NULL
mean	NULL
values	NULL
+	NULL
SD	NULL
from	NULL
three	NULL
different	NULL
experiments	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
lymphocytes	NULL
.	NULL

One	NULL
could	NULL
speculate	NULL
that	NULL
CD45	NULL
association	NULL
to	NULL
signaling	NULL
rafts	NULL
differs	NULL
in	NULL
lymphocytes	NULL
vs	NULL
lymphoblasts	NULL
,	NULL
and	NULL
that	NULL
the	NULL
various	NULL
CD45	NULL
epitopes	NULL
differentially	NULL
regulate	NULL
intracellular	NULL
signaling	NULL
complexes	NULL
present	NULL
in	NULL
the	NULL
adjacent	NULL
signaling	NULL
rafts	NULL
.	NULL

These	NULL
findings	NULL
again	NULL
highlight	NULL
the	NULL
unique	NULL
role	NULL
of	NULL
CD45	NULL
among	NULL
cellular	NULL
surface	NULL
molecules	NULL
.	NULL

CD45RO	NULL
mAb	NULL
UCHL-1	NULL
showed	NULL
similar	NULL
efficacy	NULL
in	NULL
limiting	NULL
y	NULL
,	NULL
cytokine-mediated	NULL
lymphoblast	NULL
proliferation	NULL
independent	NULL
of	NULL
the	NULL
cytokine	NULL
used	NULL
.	NULL

Vice	NULL
versa	NULL
,	NULL
cosignaling	NULL
through	NULL
OKT-3	NULL
was	NULL
more	NULL
effective	NULL
in	NULL
preventing	NULL
UCHL-1-mediated	NULL
inhibition	NULL
of	NULL
IL-4-	NULL
or	NULL
IL-7-stimulated	NULL
cell	NULL
growth	NULL
.	NULL

In	NULL
experiments	NULL
studying	NULL
intracellular	NULL
signaling	NULL
events	NULL
,	NULL
we	NULL
found	NULL
that	NULL
signaling	NULL
through	NULL
CD45RO	NULL
specifically	NULL
inhibited	NULL
IL-2-triggered	NULL
phosphorylation	NULL
of	NULL
STAT-3	NULL
,	NULL
STAT-5	NULL
,	NULL
and	NULL
ERK-1/2	NULL
as	NULL
well	NULL
as	NULL
IL-4-stimulated	NULL
phosphorylation	NULL
of	NULL
STAT-3	NULL
and	NULL
STAT-6	NULL
.	NULL

STAT	NULL
proteins	NULL
are	NULL
activated	NULL
through	NULL
members	NULL
of	NULL
the	NULL
Janus	NULL
kinase	NULL
(	NULL
Jak	NULL
)	NULL
family	NULL
(	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
Jak3	NULL
,	NULL
Tyk2	NULL
)	NULL
which	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
many	NULL
cellular	NULL
functions	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
our	NULL
findings	NULL
,	NULL
one	NULL
could	NULL
speculate	NULL
that	NULL
CD45	NULL
signals	NULL
regulate	NULL
STAT	NULL
phosphorylation	NULL
through	NULL
differential	NULL
activation	NULL
of	NULL
Jak1	NULL
or	NULL
Jak3	NULL
in	NULL
human	NULL
lymphoblasts	NULL
.	NULL

Indeed	NULL
,	NULL
Irie-Sasaki	NULL
et	NULL
al	NULL
.	NULL

(	NULL
49	NULL
)	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
in	NULL
CD45-negative	NULL
cell	NULL
lines	NULL
(	NULL
lymphocytic	NULL
,	NULL
monocytic	NULL
,	NULL
mast	NULL
cells	NULL
)	NULL
and	NULL
mice	NULL
the	NULL
cell-associated	NULL
members	NULL
of	NULL
the	NULL
Jak	NULL
family	NULL
as	NULL
well	NULL
as	NULL
STAT-1	NULL
,	NULL
STAT-3	NULL
,	NULL
or	NULL
STAT-5	NULL
are	NULL
hy-perphosphorylated	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
authors	NULL
provide	NULL
evidence	NULL
for	NULL
a	NULL
direct	NULL
association	NULL
of	NULL
Jak2	NULL
with	NULL
the	NULL
intracellular	NULL
phosphatase	NULL
domains	NULL
of	NULL
CD45	NULL
in	NULL
vitro	NULL
,	NULL
leading	NULL
to	NULL
dephosphorylation	NULL
(	NULL
49	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
clearly	NULL
support	NULL
our	NULL
hypothesis	NULL
of	NULL
a	NULL
regulation	NULL
of	NULL
STAT	NULL
phosphorylation	NULL
by	NULL
CD45	NULL
signals	NULL
(	NULL
as	NULL
shown	NULL
in	NULL
this	NULL
paper	NULL
)	NULL
through	NULL
a	NULL
direct	NULL
deactivation	NULL
of	NULL
Jak1	NULL
and/or	NULL
Jak3	NULL
in	NULL
human	NULL
lymphoblasts	NULL
.	NULL

PHA-stimulated	NULL
and	NULL
IL-2-expanded	NULL
lymphoblasts	NULL
readily	NULL
undergo	NULL
apoptosis	NULL
when	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
:	NULL
y	NULL
,	NULL
cytokines	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
signaling	NULL
through	NULL
€D95	NULL
,	NULL
steroid	NULL
receptors	NULL
,	NULL
or	NULL
addition	NULL
of	NULL
chemotherapeutic	NULL
agents	NULL
like	NULL
daunorubicine	NULL
or	NULL
etoposide	NULL
leads	NULL
to	NULL
programmed	NULL
cell	NULL
death	NULL
in	NULL
a	NULL
large	NULL
proportion	NULL
of	NULL
these	NULL
cells	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
hypothesized	NULL
that	NULL
inhibition	NULL
of	NULL
proliferation	NULL
in	NULL
these	NULL
highly	NULL
activated	NULL
cells	NULL
must	NULL
consequently	NULL
lead	NULL
to	NULL
apoptosis	NULL
.	NULL

However	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Results	NULL
,	NULL
despite	NULL
considerable	NULL
inhibition	NULL
of	NULL
proliferation	NULL
we	NULL
did	NULL
not	NULL
see	NULL
induction	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
over	NULL
the	NULL
background	NULL
level	NULL
in	NULL
these	NULL
apoptosis-prone	NULL
lymphoblasts	NULL
in	NULL
response	NULL
to	NULL
CD45	NULL
signals	NULL
.	NULL

We	NULL
could	NULL
recently	NULL
confirm	NULL
these	NULL
results	NULL
in	NULL
experiments	NULL
in	NULL
which	NULL
we	NULL
almost	NULL
completely	NULL
suppressed	NULL
cytokine-mediated	NULL
proliferation	NULL
in	NULL
lymphoblasts	NULL
by	NULL
addition	NULL
of	NULL
agents	NULL
inhibiting	NULL
various	NULL
intracellular	NULL
signaling	NULL
kinases	NULL
.	NULL

Under	NULL
those	NULL
conditions	NULL
we	NULL
did	NULL
not	NULL
find	NULL
a	NULL
relevant	NULL
increase	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
(	NULL
Ref	NULL
.	NULL

51	NULL
;	NULL
C.	NULL
Gabler	NULL
,	NULL
T.	NULL
Hieronymus	NULL
,	NULL
N.	NULL
Blank	NULL
,	NULL
M.	NULL
Schiller	NULL
,	NULL
J.	NULL
H.	NULL
Berden	NULL
,	NULL
S.	NULL
Winkler	NULL
,	NULL
J.	NULL
R.	NULL
Kalden	NULL
,	NULL
and	NULL
H.-M.	NULL
Lorenz	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

These	NULL
data	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
regulation	NULL
of	NULL
proliferation	NULL
and	NULL
apoptosis	NULL
are	NULL
not	NULL
necessarily	NULL
interrelated	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
this	NULL
paper	NULL
,	NULL
human	NULL
lymphoblasts	NULL
display	NULL
a	NULL
dual	NULL
role	NULL
which	NULL
is	NULL
differentially	NULL
regulated	NULL
.	NULL

On	NULL
the	NULL
one	NULL
hand	NULL
,	NULL
there	NULL
is	NULL
proliferation	NULL
and	NULL
survival	NULL
which	NULL
is	NULL
dependent	NULL
on	NULL
exocrine	NULL
stimulation	NULL
with	NULL
y.	NULL
,	NULL
cytokines	NULL
(	NULL
we	NULL
found	NULL
no	NULL
autocrine	NULL
production	NULL
of	NULL
IL-2	NULL
and	NULL
IL-4	NULL
by	NULL
lymphoblasts	NULL
)	NULL
.	NULL

This	NULL
response	NULL
is	NULL
mediated	NULL
through	NULL
Jak/	NULL
STAT	NULL
signaling	NULL
events	NULL
and	NULL
is	NULL
controlled	NULL
by	NULL
€D45	NULL
stimuli	NULL
as	NULL
demonstrated	NULL
in	NULL
this	NULL
paper	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
there	NULL
is	NULL
production	NULL
of	NULL
cytokines	NULL
which	NULL
clearly	NULL
do	NULL
not	NULL
contribute	NULL
to	NULL
proliferation	NULL
and	NULL
survival	NULL
(	NULL
Ref	NULL
.	NULL

41	NULL
and	NULL
C.	NULL
Gabler	NULL
,	NULL
T.	NULL
Hieronymus	NULL
,	NULL
N.	NULL
Blank	NULL
,	NULL
M.	NULL
Schiller	NULL
,	NULL
J.	NULL
H.	NULL
Berden	NULL
,	NULL
S.	NULL
Winkler	NULL
,	NULL
J.	NULL
R.	NULL
Kalden	NULL
,	NULL
and	NULL
H.-M.	NULL
Lorenz	NULL
,	NULL
unpublished	NULL
observation	NULL
)	NULL
and	NULL
might	NULL
stimulate	NULL
neighboring	NULL
APCs	NULL
or	NULL
lymphocytes/lymphoblasts	NULL
(	NULL
TNF-	NULL
«	NULL
@	NULL
,	NULL
IFN-y	NULL
,	NULL
IL-5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
synthesis	NULL
of	NULL
these	NULL
cytokines	NULL
is	NULL
supported	NULL
by	NULL
signals	NULL
through	NULL
the	NULL
y	NULL
,	NULL
,	NULL
cytokine	NULL
receptors	NULL
and	NULL
TCR-CD3	NULL
complex	NULL
,	NULL
but	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
proliferative	NULL
response	NULL
,	NULL
can	NULL
not	NULL
be	NULL
inhibited	NULL
by	NULL
CD45	NULL
signals	NULL
(	NULL
Figs	NULL
.	NULL

6039	NULL
6-8	NULL
)	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
secretion	NULL
of	NULL
these	NULL
cytokines	NULL
occurs	NULL
independent	NULL
of	NULL
STAT/ERK	NULL
signaling	NULL
molecules	NULL
.	NULL

Our	NULL
data	NULL
collectively	NULL
associate	NULL
y.	NULL
cytokine	NULL
signaling	NULL
events	NULL
with	NULL
CD45	NULL
-regulated	NULL
intracellular	NULL
signaling	NULL
processes	NULL
in	NULL
nonlineage	NULL
human	NULL
lymphoblasts	NULL
and	NULL
again	NULL
highlight	NULL
the	NULL
dominant	NULL
role	NULL
for	NULL
€D45	NULL
in	NULL
influencing	NULL
early	NULL
cellular	NULL
activation	NULL
steps	NULL
in	NULL
human	NULL
lymphocytes	NULL
and	NULL
lymphoblasts	NULL
.	NULL

Recently	NULL
,	NULL
CD45	NULL
was	NULL
discussed	NULL
as	NULL
membranous	NULL
gatekeeper	NULL
determining	NULL
early	NULL
intracellular	NULL
signaling	NULL
events	NULL
by	NULL
influencing	NULL
phosphorylation	NULL
or	NULL
dephosphorylation	NULL
of	NULL
associated	NULL
proteins	NULL
organized	NULL
in	NULL
lipid	NULL
microdomains	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Extraction	NULL
of	NULL
plasma	NULL
membrane	NULL
proteins	NULL
with	NULL
certain	NULL
nonionic	NULL
detergents	NULL
at	NULL
cold	NULL
temperatures	NULL
results	NULL
in	NULL
segregation	NULL
of	NULL
constituents	NULL
into	NULL
soluble	NULL
and	NULL
insoluble	NULL
fractions	NULL
.	NULL

The	NULL
insoluble	NULL
fraction	NULL
is	NULL
enriched	NULL
in	NULL
choles-terol	NULL
,	NULL
glycosphingolipids	NULL
,	NULL
membrane	NULL
proteins	NULL
linked	NULL
to	NULL
glycophos-phatidylinositol	NULL
,	NULL
and	NULL
certain	NULL
signaling	NULL
proteins	NULL
including	NULL
src	NULL
family	NULL
kinases	NULL
,	NULL
CD3/TCR	NULL
,	NULL
CD4	NULL
or	NULL
CD8	NULL
,	NULL
and	NULL
linker	NULL
for	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
35	NULL
,	NULL
52-54	NULL
)	NULL
.	NULL

It	NULL
was	NULL
concluded	NULL
that	NULL
signaling	NULL
molecules	NULL
differentially	NULL
and	NULL
specifically	NULL
translocate	NULL
into	NULL
membrane	NULL
microdomains	NULL
after	NULL
activation	NULL
.	NULL

The	NULL
role	NULL
of	NULL
€D45	NULL
in	NULL
controlling	NULL
signaling	NULL
processes	NULL
through	NULL
these	NULL
microdomains	NULL
is	NULL
still	NULL
disputed	NULL
.	NULL

It	NULL
has	NULL
previously	NULL
been	NULL
noted	NULL
that	NULL
the	NULL
extracellular	NULL
domain	NULL
of	NULL
CD45	NULL
is	NULL
much	NULL
larger	NULL
in	NULL
size	NULL
when	NULL
compared	NULL
with	NULL
the	NULL
Ag	NULL
receptor	NULL
and	NULL
low	NULL
molecular	NULL
mass	NULL
signaling	NULL
molecules	NULL
(	NULL
35	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
CD45	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
recruited	NULL
to	NULL
the	NULL
contact	NULL
area	NULL
of	NULL
a	NULL
T	NULL
cell	NULL
with	NULL
an	NULL
APC	NULL
(	NULL
55	NULL
,	NULL
56	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
was	NULL
hypothesized	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
that	NULL
CD45	NULL
is	NULL
excluded	NULL
from	NULL
membrane	NULL
microdomains	NULL
,	NULL
but	NULL
must	NULL
be	NULL
in	NULL
close	NULL
proximity	NULL
to	NULL
the	NULL
signaling	NULL
rafts	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
it	NULL
will	NULL
be	NULL
of	NULL
great	NULL
interest	NULL
to	NULL
investigate	NULL
formation	NULL
of	NULL
microdomains	NULL
in	NULL
lympho-kine-stimulated	NULL
lymphoblasts	NULL
and	NULL
to	NULL
study	NULL
the	NULL
differential	NULL
role	NULL
of	NULL
CD45-phosphatase	NULL
in	NULL
influencing	NULL
signaling	NULL
processes	NULL
in	NULL
these	NULL
lymphoblasts	NULL
.	NULL

Acknowledgments	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
Drs	NULL
.	NULL

P.	NULL
Beverly	NULL
,	NULL
J.	NULL
Byrne	NULL
,	NULL
B.	NULL
Schraven	NULL
,	NULL
and	NULL
S.	NULL
Meuer	NULL
for	NULL
generously	NULL
providing	NULL
Abs	NULL
and	NULL
hybridoma	NULL
cells	NULL
as	NULL
stated	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Kicner	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
Mittler	NULL
.	NULL

1989	NULL
.	NULL

CD45-protein	NULL
tyrosine	NULL
phosphatase	NULL
cross-linking	NULL
inhibits	NULL
CD3-mediated	NULL
activation	NULL
in	NULL
human	NULL
T-cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:23	NULL
.	NULL

2	NULL
.	NULL

Stamenkovie	NULL
,	NULL
L.	NULL
,	NULL
D.	NULL
Sgroi	NULL
,	NULL
A.	NULL
Aruffo	NULL
,	NULL
M.	NULL
S.	NULL
Sy	NULL
,	NULL
and	NULL
T.	NULL
Anderson	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
B	NULL
lymphocyte	NULL
adhesion	NULL
molecule	NULL
CD22	NULL
interacts	NULL
with	NULL
leukocyte	NULL
common	NULL
antigen	NULL
CD45RO	NULL
on	NULL
T	NULL
cells	NULL
and	NULL
«	NULL
2-6	NULL
sialyItransferase	NULL
,	NULL
CD75	NULL
,	NULL
on	NULL
B	NULL
cells	NULL
.	NULL

Cell	NULL
66:1133	NULL
.	NULL

3	NULL
.	NULL

Lorenz	NULL
,	NULL
H.-M.	NULL
,	NULL
T.	NULL
Harrer	NULL
,	NULL
A.	NULL
S.	NULL
Lagoo	NULL
,	NULL
A.	NULL
Baur	NULL
,	NULL
G.	NULL
Eger	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Kalden	NULL
.	NULL

1993	NULL
.	NULL

CD45	NULL
mAb	NULL
induces	NULL
cell	NULL
adhesion	NULL
in	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
via	NULL
lymphocyte	NULL
function-associated	NULL
antigen-1	NULL
(	NULL
LFA-1	NULL
)	NULL
and	NULL
intercellular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
ICAM-1	NULL
)	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

147:110	NULL
.	NULL

4	NULL
.	NULL

Morikawa	NULL
,	NULL
K.	NULL
,	NULL
F.	NULL
Oseko	NULL
,	NULL
and	NULL
S.	NULL
Morikawa	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
role	NULL
of	NULL
CD45RA	NULL
on	NULL
human	NULL
B-cell	NULL
function	NULL
:	NULL
anti-CD45RA	NULL
antibody	NULL
(	NULL
anti-2H4	NULL
)	NULL
inhibits	NULL
the	NULL
activation	NULL
of	NULL
resting	NULL
B	NULL
cells	NULL
and	NULL
antibody	NULL
production	NULL
of	NULL
activated	NULL
B	NULL
cells	NULL
independently	NULL
in	NULL
humans	NULL
.	NULL

Scand	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

34:273	NULL
.	NULL

5	NULL
.	NULL

Hasegawa	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Nishimura	NULL
,	NULL
S.	NULL
Ogawa	NULL
,	NULL
S.	NULL
Hirose	NULL
,	NULL
H.	NULL
Sato	NULL
,	NULL
and	NULL
T.	NULL
Shirai	NULL
.	NULL

1990	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
to	NULL
epitope	NULL
of	NULL
CD4SR	NULL
(	NULL
B220	NULL
)	NULL
inhibit	NULL
interleukin	NULL
4-medi-ated	NULL
B	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

2:367	NULL
.	NULL

6	NULL
.	NULL

Mittler	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
B.	NULL
M.	NULL
Rankin	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Kiener	NULL
.	NULL

1991	NULL
.	NULL

Physical	NULL
associations	NULL
between	NULL
CD45	NULL
and	NULL
CD4	NULL
or	NULL
CD8	NULL
occur	NULL
as	NULL
late	NULL
activation	NULL
events	NULL
in	NULL
antigen	NULL
receptor-stimulated	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:3434	NULL
.	NULL

7	NULL
.	NULL

Hook	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
E.	NULL
H.	NULL
Berenstein	NULL
,	NULL
F.	NULL
U.	NULL
Zinsser	NULL
,	NULL
C.	NULL
Fischler	NULL
,	NULL
and	NULL
R.	NULL
P.	NULL
Siraganian	NULL
.	NULL

1991	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
to	NULL
the	NULL
leukocyte	NULL
common	NULL
antigen	NULL
(	NULL
CD45	NULL
)	NULL
inhibit	NULL
IgE-mediated	NULL
histamine	NULL
release	NULL
from	NULL
human	NULL
basophils	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:2670	NULL
.	NULL

8	NULL
.	NULL

Justement	NULL
,	NULL
L.	NULL
B.	NULL
,	NULL
K.	NULL
S.	NULL
Campbell	NULL
,	NULL
N.	NULL
C.	NULL
Chien	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Cambier	NULL
.	NULL

1991	NULL
.	NULL

Regulation	NULL
of	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
signal	NULL
transduction	NULL
and	NULL
phosphorylation	NULL
by	NULL
CD45	NULL
.	NULL

Science	NULL
252:1839	NULL
.	NULL

9	NULL
.	NULL

Pingel	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Thomas	NULL
.	NULL

1989	NULL
.	NULL

Evidence	NULL
,	NULL
that	NULL
the	NULL
leukocyte-common	NULL
antigen	NULL
is	NULL
required	NULL
for	NULL
antigen-induced	NULL
T	NULL
lymphocyte	NULL
proliferation	NULL
.	NULL

Cell	NULL
58:1055	NULL
.	NULL

10	NULL
.	NULL

Deans	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
S.	NULL
B.	NULL
Kanner	NULL
,	NULL
R.	NULL
M.	NULL
Torres	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
.	NULL

1992	NULL
.	NULL

Interaction	NULL
of	NULL
CD4	NULL
:	NULL
Ick	NULL
with	NULL
the	NULL
T	NULL
cell	NULL
receptor/CD3	NULL
complex	NULL
induces	NULL
early	NULL
signaling	NULL
events	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CD45	NULL
tyrosine	NULL
phosphatase	NULL
.	NULL

Kur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22:661	NULL
.	NULL

11	NULL
.	NULL

Weaver	NULL
,	NULL
C.	NULL
T.	NULL
,	NULL
J.	NULL
T.	NULL
Pingel	NULL
,	NULL
J.	NULL
O.	NULL
Nelson	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Thomas	NULL
.	NULL

1991	NULL
.	NULL

CD8	NULL
*	NULL
T-cell	NULL
clones	NULL
deficient	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
CD45	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
have	NULL
impaired	NULL
responses	NULL
to	NULL
T-cell	NULL
receptor	NULL
stimuli	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:4415	NULL
.	NULL

12	NULL
.	NULL

Koretzky	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
J.	NULL
Picus	NULL
,	NULL
T.	NULL
Schultz	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1991	NULL
.	NULL

Tyrosine	NULL
phosphatase	NULL
CD45	NULL
is	NULL
required	NULL
for	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
and	NULL
CD2-mediated	NULL
activation	NULL
of	NULL
a	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6040	NULL
13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34.	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
and	NULL
interleukin	NULL
2	NULL
production	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:2037	NULL
.	NULL

Koretzky	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
M.	NULL
A.	NULL
Kohmetscher	NULL
,	NULL
T.	NULL
Kadleck	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1992	NULL
.	NULL

Restoration	NULL
of	NULL
T	NULL
cell	NULL
receptor-mediated	NULL
signal	NULL
transduction	NULL
by	NULL
transfection	NULL
of	NULL
CD45	NULL
cDNA	NULL
into	NULL
a	NULL
CD45-deficient	NULL
variant	NULL
of	NULL
the	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149	NULL
;	NULL
1138	NULL
.	NULL

Koretzky	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
J.	NULL
Picus	NULL
,	NULL
M.	NULL
L.	NULL
Thomas	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1990	NULL
.	NULL

Tyrosine	NULL
phosphatase	NULL
CD45	NULL
is	NULL
essential	NULL
for	NULL
coupling	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
to	NULL
the	NULL
phosphatidyl	NULL
inositol	NULL
pathway	NULL
.	NULL

Nature	NULL
346:66	NULL
.	NULL

Trowbridge	NULL
,	NULL
I.	NULL
S.	NULL
1991	NULL
.	NULL

CD45	NULL
:	NULL
a	NULL
prototype	NULL
for	NULL
transmembrane	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:23517	NULL
.	NULL

Fischer	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
H.	NULL
Charbonneau	NULL
,	NULL
and	NULL
N.	NULL
K.	NULL
Tonks	NULL
.	NULL

1991	NULL
.	NULL

Protein	NULL
tyrosine	NULL
phosphatases	NULL
:	NULL
a	NULL
diverse	NULL
family	NULL
of	NULL
intracellular	NULL
and	NULL
transmembrane	NULL
enzymes	NULL
.	NULL

Science	NULL
253:401	NULL
.	NULL

Charbonneau	NULL
,	NULL
H.	NULL
,	NULL
N.	NULL
K.	NULL
Tonks	NULL
,	NULL
K.	NULL
A.	NULL
Walsh	NULL
,	NULL
and	NULL
E.	NULL
H.	NULL
Fischer	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
leukocyte	NULL
common	NULL
antigen	NULL
(	NULL
CD45	NULL
)	NULL
:	NULL
a	NULL
putative	NULL
receptor-linked	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:7182	NULL
.	NULL

Tonks	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
C.	NULL
D.	NULL
Diltz	NULL
,	NULL
and	NULL
E.	NULL
H.	NULL
Fischer	NULL
.	NULL

1990	NULL
.	NULL

CD45	NULL
,	NULL
an	NULL
integral	NULL
membrane	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:10674	NULL
.	NULL

Ostergaard	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Trowbridge	NULL
.	NULL

1990	NULL
.	NULL

Coclustering	NULL
CD45	NULL
with	NULL
CD4	NULL
or	NULL
CD8	NULL
alters	NULL
the	NULL
phosphorylation	NULL
and	NULL
kinase	NULL
activity	NULL
of	NULL
p56®**	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172	NULL
:	NULL
347	NULL
.	NULL

Schraven	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
Schirren	NULL
,	NULL
H.	NULL
Kirchgessner	NULL
,	NULL
B.	NULL
Sicbert	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Meuer	NULL
.	NULL

1992	NULL
.	NULL

Four	NULL
CD45/p56	NULL
``	NULL
**-associated	NULL
phosphorproteins	NULL
(	NULL
pp29-pp32	NULL
)	NULL
undergo	NULL
alterations	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22:1857	NULL
.	NULL

Shiroo	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Goff	NULL
,	NULL
M.	NULL
Biffen	NULL
,	NULL
E.	NULL
Shivnan	NULL
,	NULL
and	NULL
D.	NULL
Alexander	NULL
.	NULL

1992	NULL
.	NULL

CD45	NULL
tyrosine	NULL
phosphatase-activated	NULL
p59°Y	NULL
``	NULL
couples	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
to	NULL
pathways	NULL
of	NULL
diacylglycerol	NULL
production	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
activation	NULL
and	NULL
calcium	NULL
in-flux	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:4887	NULL
.	NULL

Turka	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
S.	NULL
B.	NULL
Kanner	NULL
,	NULL
G.	NULL
L.	NULL
Schieven	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
.	NULL

1992	NULL
.	NULL

CD45	NULL
modulates	NULL
T	NULL
cell	NULL
receptor/CD3-induced	NULL
activation	NULL
of	NULL
human	NULL
thymocytes	NULL
via	NULL
regulation	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22:551	NULL
.	NULL

Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
G.	NULL
L.	NULL
Schieven	NULL
,	NULL
F.	NULL
M.	NULL
Uckun	NULL
,	NULL
and	NULL
J	NULL
.	NULL

B.	NULL
Imboden	NULL
.	NULL

1991	NULL
.	NULL

CD45	NULL
cross-linking	NULL
regulates	NULL
phospholipase	NULL
C	NULL
activation	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
specific	NULL
substrates	NULL
in	NULL
CD3/Ti-stimulated	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:1577	NULL
.	NULL

Kanner	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
J.	NULL
P.	NULL
Deans	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
.	NULL

1992	NULL
.	NULL

Regulation	NULL
of	NULL
CD3-induced	NULL
phospholipase	NULL
C-y1	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
CD4	NULL
and	NULL
CD45	NULL
receptors	NULL
.	NULL

Immunology	NULL
75:441	NULL
.	NULL

Desai	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
J.	NULL
Sap	NULL
,	NULL
J.	NULL
Schlessinger	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1993	NULL
.	NULL

Ligand-mediated	NULL
negative	NULL
regulation	NULL
of	NULL
a	NULL
chimeric	NULL
transmembrane	NULL
receptor	NULL
tyrosine	NULL
phosphatase	NULL
.	NULL

Cell	NULL
73:541	NULL
.	NULL

Majeti	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
M.	NULL
Bilwes	NULL
,	NULL
J.	NULL
P.	NULL
Noel	NULL
,	NULL
T.	NULL
Hunter	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1998	NULL
.	NULL

Dimeriza-tion-induced	NULL
inhibition	NULL
of	NULL
receptor	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
function	NULL
through	NULL
an	NULL
inhibitory	NULL
wedge	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

279:88	NULL
.	NULL

D'Oro	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
D.	NULL
Ashwell	NULL
.	NULL

1999	NULL
.	NULL

Cutting	NULL
edge	NULL
:	NULL
the	NULL
CD45	NULL
tyrosine	NULL
phosphatase	NULL
is	NULL
an	NULL
inhibitor	NULL
of	NULL
Ick	NULL
activity	NULL
in	NULL
thymocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:1879	NULL
.	NULL

Thomas	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
E.	NULL
J	NULL
.	NULL

Brown	NULL
.	NULL

1999	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
src-family	NULL
membrane	NULL
kinases	NULL
by	NULL
CD45	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
20:406	NULL
.	NULL

Schwinzer	NULL
,	NULL
R.	NULL
1989	NULL
.	NULL

Cluster	NULL
report	NULL
:	NULL
CD45/CD45R	NULL
.	NULL

In	NULL
Leukocyte	NULL
Typing	NULL
IV	NULL
.	NULL

W.	NULL
Knapp	NULL
,	NULL
B.	NULL
Diorken	NULL
,	NULL
W.	NULL
R.	NULL
Gilks	NULL
,	NULL
E.	NULL
P.	NULL
Ricber	NULL
,	NULL
H.	NULL
Schmidt	NULL
,	NULL
H.	NULL
Stein	NULL
,	NULL
and	NULL
A.	NULL
E.	NULL
G.	NULL
K.	NULL
Von	NULL
dem	NULL
Borne	NULL
,	NULL
eds	NULL
.	NULL

Oxford	NULL
Univ	NULL
.	NULL

Press	NULL
,	NULL
Oxford	NULL
,	NULL
p.	NULL
628	NULL
.	NULL

Schraven	NULL
,	NULL
B.	NULL
,	NULL
M.	NULL
Roux	NULL
,	NULL
B.	NULL
Hutmacher	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Meuer	NULL
.	NULL

1989	NULL
.	NULL

Triggering	NULL
of	NULL
the	NULL
alternative	NULL
pathway	NULL
of	NULL
human	NULL
T-cell	NULL
activation	NULL
involves	NULL
members	NULL
of	NULL
the	NULL
T200	NULL
family	NULL
of	NULL
glycoproteins	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

19:397	NULL
.	NULL

Alsinet	NULL
,	NULL
E.	NULL
,	NULL
J.	NULL
Ingles-Esteve	NULL
,	NULL
R.	NULL
Vilela	NULL
,	NULL
F.	NULL
Lozano	NULL
,	NULL
J.	NULL
Mila	NULL
,	NULL
I.	NULL
Rojo	NULL
,	NULL
J.	NULL
Martorell	NULL
,	NULL
J.	NULL
Vives	NULL
,	NULL
and	NULL
A.	NULL
Gaya	NULL
.	NULL

1990	NULL
.	NULL

Differential	NULL
effects	NULL
of	NULL
anti-CD45	NULL
monoclonal	NULL
antibody	NULL
on	NULL
human	NULL
B	NULL
cell	NULL
proliferation	NULL
:	NULL
a	NULL
monoclonal	NULL
antibody	NULL
recognizing	NULL
a	NULL
neura-minidase-sensitive	NULL
epitope	NULL
of	NULL
the	NULL
T200	NULL
molecule	NULL
enhances	NULL
anti-immunoglobulin-induced	NULL
proliferation	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

20:2801	NULL
.	NULL

Marvel	NULL
,	NULL
J.	NULL
,	NULL
G.	NULL
Rimon	NULL
,	NULL
P.	NULL
Tatham	NULL
,	NULL
and	NULL
S.	NULL
Cockcroft	NULL
.	NULL

1991	NULL
.	NULL

Evidence	NULL
that	NULL
the	NULL
CD45	NULL
phosphatase	NULL
regulates	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
phospholipase	NULL
C	NULL
in	NULL
mouse	NULL
T	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

21:195	NULL
.	NULL

Samelson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
M.	NULL
C.	NULL
Fletcher	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
and	NULL
C.	NULL
H.	NULL
June	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
via	NULL
the	NULL
CD2	NULL
pathway	NULL
:	NULL
regulation	NULL
by	NULL
the	NULL
CD45	NULL
tyrosine	NULL
phosphatase	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145:2448	NULL
.	NULL

Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
N.	NULL
K.	NULL
Tonks	NULL
,	NULL
E.	NULL
H.	NULL
Fischer	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
Clark	NULL
.	NULL

1988	NULL
.	NULL

CD45	NULL
regulates	NULL
signal	NULL
transduction	NULL
and	NULL
lymphocyte	NULL
activation	NULL
by	NULL
specific	NULL
association	NULL
with	NULL
receptor	NULL
molecules	NULL
on	NULL
T-	NULL
or	NULL
B-cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:8628	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

CD45	NULL
CONTROLS	NULL
STAT	NULL
AND	NULL
ERK	NULL
PHOSPHORYLATION	NULL
Thomas	NULL
,	NULL
M.	NULL
L.	NULL
1999	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
antigen-receptor	NULL
signaling	NULL
by	NULL
protein	NULL
tyrosine	NULL
phosphatases	NULL
:	NULL
a	NULL
hole	NULL
in	NULL
the	NULL
story	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

11:270	NULL
.	NULL

Rodgers	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
J.	NULL
K.	NULL
Rose	NULL
.	NULL

1996	NULL
.	NULL

Exclusion	NULL
of	NULL
CD45	NULL
inhibits	NULL
activity	NULL
of	NULL
p56	NULL
associated	NULL
with	NULL
glycolipid-enriched	NULL
membrane	NULL
domains	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

135:1515	NULL
.	NULL

Lorenz	NULL
,	NULL
H.-M.	NULL
,	NULL
A.	NULL
S.	NULL
Lagoo	NULL
,	NULL
and	NULL
K.	NULL
J.	NULL
Hardy	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
cell	NULL
and	NULL
molecular	NULL
basis	NULL
for	NULL
CD45	NULL
triggered	NULL
,	NULL
LFA-1/ICAM-1	NULL
dependent	NULL
,	NULL
leukocyte	NULL
adhesion	NULL
.	NULL

Blood	NULL
83	NULL
:	NULL
1862	NULL
.	NULL

Lorenz	NULL
,	NULL
H-M.	NULL
,	NULL
A.	NULL
S.	NULL
Lagoo	NULL
,	NULL
S.	NULL
A.	NULL
Lagoo-Deenadalayan	NULL
,	NULL
W.	NULL
H.	NULL
Barber	NULL
,	NULL
J.	NULL
R.	NULL
Kalden	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Hardy	NULL
.	NULL

1998	NULL
.	NULL

Epitope-specific	NULL
signaling	NULL
through	NULL
CD45	NULL
on	NULL
T	NULL
lymphocytes	NULL
leads	NULL
to	NULL
cAMP	NULL
synthesis	NULL
in	NULL
monocytes	NULL
after	NULL
ICAM-1-dependent	NULL
cellular	NULL
interaction	NULL
.	NULL

Fur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28:2300	NULL
.	NULL

Nicoletti	NULL
,	NULL
I.	NULL
,	NULL
G.	NULL
Migliorati	NULL
,	NULL
M.	NULL
C.	NULL
Pagliacci	NULL
,	NULL
F.	NULL
Grignani	NULL
,	NULL
and	NULL
C.	NULL
Riccardi	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
rapid	NULL
and	NULL
simple	NULL
method	NULL
for	NULL
measuring	NULL
thymocyte	NULL
apoptosis	NULL
by	NULL
propidium	NULL
iodide	NULL
staining	NULL
and	NULL
flow	NULL
cytometry	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
139:271	NULL
.	NULL

Lagoo-Deenadayalan	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
S.	NULL
Lagoo	NULL
,	NULL
W.	NULL
H.	NULL
Barber	NULL
,	NULL
and	NULL
K.	NULL
J.	NULL
Hardy	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
standardized	NULL
approach	NULL
to	NULL
PCR-based	NULL
semiquantitation	NULL
of	NULL
multiple	NULL
cytokine	NULL
gene	NULL
transcripts	NULL
from	NULL
small	NULL
cell	NULL
samples	NULL
.	NULL

Lymphokine	NULL
Cytokine	NULL
Res	NULL
.	NULL

12:59	NULL
.	NULL

Lorenz	NULL
,	NULL
H.-M.	NULL
,	NULL
T.	NULL
Hieronymus	NULL
,	NULL
M.	NULL
Griinke	NULL
,	NULL
B.	NULL
Manger	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Kalden	NULL
.	NULL

1997	NULL
.	NULL

Differential	NULL
role	NULL
for	NULL
IL-2	NULL
and	NULL
IL-15	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
in	NULL
short	NULL
term	NULL
activated	NULL
human	NULL
lymphocytes	NULL
.	NULL

Scand	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

45:660	NULL
.	NULL

Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
C.	NULL
M.	NULL
Bacon	NULL
,	NULL
M.	NULL
C.	NULL
Riedy	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O'Shea	NULL
.	NULL

1996	NULL
.	NULL

Signaling	NULL
by	NULL
IL-2	NULL
and	NULL
related	NULL
cytokines	NULL
:	NULL
JAKs	NULL
,	NULL
STATs	NULL
,	NULL
and	NULL
relationship	NULL
to	NULL
immunodeficiency	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

60:441	NULL
.	NULL

Gesbert	NULL
,	NULL
F.	NULL
,	NULL
M.	NULL
Delespine-Carmagnat	NULL
,	NULL
and	NULL
J.	NULL
Bertoglio	NULL
.	NULL

1998	NULL
.	NULL

Recent	NULL
advances	NULL
in	NULL
the	NULL
understanding	NULL
of	NULL
interleukin-2	NULL
signal	NULL
transduction	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

18:307.	NULL
.	NULL

Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
C.	NULL
M.	NULL
Bacon	NULL
,	NULL
D.	NULL
S.	NULL
Finbloom	NULL
,	NULL
R.	NULL
C.	NULL
Rees	NULL
,	NULL
D.	NULL
Kaplan	NULL
,	NULL
K.	NULL
Shibuya	NULL
,	NULL
J.	NULL
R.	NULL
Ortaldo	NULL
,	NULL
S.	NULL
Gupta	NULL
,	NULL
Y.	NULL
Q.	NULL
Chen	NULL
,	NULL
J.	NULL
D.	NULL
Giri	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O	NULL
'	NULL
Shea	NULL
.	NULL

1995	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
STATS	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
Janus	NULL
kinases	NULL
by	NULL
inter-leukins	NULL
2	NULL
and	NULL
15	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:8705	NULL
.	NULL

Algeciras-Schimnich	NULL
,	NULL
A.	NULL
,	NULL
T.	NULL
S.	NULL
Griffith	NULL
,	NULL
D.	NULL
H.	NULL
Lynch	NULL
,	NULL
and	NULL
C.	NULL
V.	NULL
Paya	NULL
.	NULL

1999	NULL
.	NULL

Cell-cycle	NULL
dependent	NULL
regulation	NULL
of	NULL
FLIP	NULL
levels	NULL
and	NULL
susceptibility	NULL
to	NULL
Fas-mediated	NULL
apoptosis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:5205	NULL
.	NULL

Di	NULL
Somma	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
F.	NULL
Somma	NULL
,	NULL
M.	NULL
S.	NULL
Montani	NULL
,	NULL
R.	NULL
Mangiacasale	NULL
,	NULL
E.	NULL
Cundari	NULL
,	NULL
and	NULL
E.	NULL
Piccolella	NULL
.	NULL

1999	NULL
.	NULL

TCR	NULL
engagement	NULL
regulates	NULL
differential	NULL
responsiveness	NULL
of	NULL
human	NULL
memory	NULL
T	NULL
cells	NULL
to	NULL
Fas	NULL
(	NULL
CD95	NULL
)	NULL
-mediated	NULL
apoptosis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:3851	NULL
.	NULL

Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O'Shea	NULL
.	NULL

1998	NULL
.	NULL

Jaks	NULL
and	NULL
STATs	NULL
:	NULL
biological	NULL
implications	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

16:293	NULL
.	NULL

Touw	NULL
,	NULL
I.	NULL
P.	NULL
,	NULL
J.	NULL
P.	NULL
De	NULL
Koning	NULL
,	NULL
A.	NULL
C.	NULL
Ward	NULL
,	NULL
and	NULL
M.	NULL
H.	NULL
Hermans	NULL
.	NULL

2000	NULL
.	NULL

Signaling	NULL
mechanisms	NULL
of	NULL
cytokine	NULL
receptors	NULL
and	NULL
their	NULL
perturbances	NULL
in	NULL
disease	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Endocrinol	NULL
.	NULL

160	NULL
:	NULL
1	NULL
.	NULL

Irie-Sasaki	NULL
,	NULL
J.	NULL
,	NULL
T.	NULL
Sasaki	NULL
,	NULL
W.	NULL
Matsumoto	NULL
,	NULL
A.	NULL
Opavsky	NULL
,	NULL
M.	NULL
Cheng	NULL
,	NULL
G.	NULL
Welstead	NULL
,	NULL
E.	NULL
Griffith	NULL
,	NULL
C.	NULL
Krawezyk	NULL
,	NULL
C.	NULL
D.	NULL
Richardson	NULL
,	NULL
K.	NULL
Aitken	NULL
,	NULL
et	NULL
al	NULL
.	NULL

2001	NULL
.	NULL

CD45	NULL
is	NULL
a	NULL
JAK	NULL
phosphatase	NULL
and	NULL
negatively	NULL
regulates	NULL
cytokine	NULL
receptor	NULL
signalling	NULL
.	NULL

Nature	NULL
409	NULL
;	NULL
349	NULL
.	NULL

Hicronymus	NULL
,	NULL
T.	NULL
,	NULL
N.	NULL
Blank	NULL
,	NULL
M.	NULL
Gruenke	NULL
,	NULL
S.	NULL
Winkler	NULL
,	NULL
J.	NULL
P.	NULL
Haas	NULL
,	NULL
J.	NULL
R.	NULL
Kalden	NULL
,	NULL
and	NULL
H.	NULL
M.	NULL
Lorenz	NULL
.	NULL

2000	NULL
.	NULL

CD95-independent	NULL
mechanisms	NULL
of	NULL
IL-2	NULL
deprivation-induced	NULL
apoptosis	NULL
in	NULL
activated	NULL
human	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
.	NULL

Death	NULL
Differ	NULL
.	NULL

7:538	NULL
.	NULL

Hicronymus	NULL
,	NULL
T.	NULL
,	NULL
N.	NULL
Blank	NULL
,	NULL
M.	NULL
Gruenke	NULL
,	NULL
S.	NULL
Winkler	NULL
,	NULL
T.	NULL
Geiler	NULL
,	NULL
J.	NULL
R.	NULL
Kalden	NULL
,	NULL
and	NULL
H.-M.	NULL
Lorenz	NULL
.	NULL

1999	NULL
.	NULL

Differential	NULL
engagement	NULL
of	NULL
intracellular	NULL
signaling	NULL
components	NULL
in	NULL
proliferation	NULL
versus	NULL
survival/apoptosis	NULL
in	NULL
activated	NULL
human	NULL
lymphoblasts	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

42:8260	NULL
.	NULL

Simons	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
E.	NULL
Ikonen	NULL
.	NULL

1997	NULL
.	NULL

Functional	NULL
rafts	NULL
in	NULL
cell	NULL
membranes	NULL
.	NULL

Nature	NULL
387:569	NULL
.	NULL

Stefanova	NULL
,	NULL
I.	NULL
,	NULL
V.	NULL
Horejsi	NULL
,	NULL
I.	NULL
J.	NULL
Ansotegui	NULL
,	NULL
W.	NULL
Knapp	NULL
,	NULL
and	NULL
H.	NULL
Stockinger	NULL
.	NULL

1991	NULL
.	NULL

GPI-anchored	NULL
cell-surface	NULL
molecules	NULL
complexed	NULL
to	NULL
protein-tyrosine	NULL
kinases	NULL
.	NULL

Science	NULL
254:1016	NULL
.	NULL

Zhang	NULL
,	NULL
W.	NULL
,	NULL
R.	NULL
P.	NULL
Trible	NULL
,	NULL
and	NULL
L.	NULL
E.	NULL
Samelson	NULL
.	NULL

1998	NULL
.	NULL

LAT	NULL
palmitoylation	NULL
:	NULL
its	NULL
essential	NULL
role	NULL
in	NULL
membrane	NULL
microdomain	NULL
targeting	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Immunity	NULL
9:239	NULL
.	NULL

Sperling	NULL
,	NULL
A.	NULL
I	NULL
,	NULL
J.	NULL
R.	NULL
Sedy	NULL
,	NULL
N.	NULL
Manjunath	NULL
,	NULL
A.	NULL
Kupfer	NULL
,	NULL
B.	NULL
Ardman	NULL
,	NULL
and	NULL
J.	NULL
K.	NULL
Burkardt	NULL
.	NULL

1998	NULL
.	NULL

TCR	NULL
signaling	NULL
induces	NULL
selective	NULL
exclusion	NULL
of	NULL
CD43	NULL
from	NULL
T	NULL
cell-antigen	NULL
presenting	NULL
cell	NULL
contact	NULL
site	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:6459	NULL
.	NULL

Johnson	NULL
,	NULL
K.	NULL
G.	NULL
,	NULL
S.	NULL
K.	NULL
Bromley	NULL
,	NULL
M.	NULL
L.	NULL
Dustin	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Thomas	NULL
.	NULL

2000	NULL
.	NULL

A	NULL
supramolecular	NULL
basis	NULL
for	NULL
CD45	NULL
tyrosine	NULL
phosphatase	NULL
regulation	NULL
in	NULL
sustained	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
97:10138	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

